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ABSTRACT
UNDERSTANDING YOUNG ADULT SURVIVORS OF CHILDHOOD CANCERS’
PARTICIPATION IN LATE EFFECTS SCREENING: A MIXED METHOD APPROACH
Kristen Trost Mantlo
Old Dominion University, 2019
Director: Dr. Richardean Benjamin
Significant advancements in the treatment of childhood cancers have helped to increase
the 5-year survival rate from 56% in the early 1970s to approximately 80-85% in the early 2000s
(Greenlee, Murray, Bolden, & Wingo, 2000; Hampton, 2005). Treatment modalities such as
chemotherapy and radiation have led to many serious long-term side effects, known as late
effects. Between 60% and 90% of survivors develop some form of long-term chronic condition
due to their treatment and up to 40% of those conditions will be life-threatening (Howlader, N. et
al., 2013). While the majority of young adult survivors of childhood cancer are at risk for
developing a late effect, most of them are not participating in recommended screening protocols
to identify late effects (Schultz et al., 2010). Current research has identified individual patient
characteristics associated with survivors’ screening practices but limited research has assessed
the health beliefs of pediatric cancer survivors. The purpose of this study was to examine the
factors that influence young adult survivors of childhood cancer participation in screening for
late-effects.
A mixed method’s design was used for this study. The quantitative portion in phase one
used a modified version of Champion’s Health Belief Model (Champion’s Health Belief Model
Scale). Participants could self-select to participate in the quantitative portion, followed by
structured interviews analyzed using a grounded theory approach. Ninety-two participants were
enrolled in phase one of the study, and 28 participants completed phase two, structured phone
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interviews. Four models were assessed using Firth Logistic Regression. Findings showed three
non-modifiable variables, age at time of survey (p<0.001), age greater than or equal 26
(p=0.029), and time since last attending a late effects appointment (p=0.02) were associated with
a survivor’s likelihood of attending a late effects appointment in the next year. Models showed a
relationship between the modifiable factors of the health belief model, perceived self-efficacy
(p=.029) and perceived threat (p=.043) with a young adult survivor’s likelihood of attending a
late effects screening appointment in the next year. Phone interviews suggested that many of the
constructs of health belief are present in a young adult survivor of childhood cancers’ health
beliefs about late effects screening appointments. While the generalizability of this study is
limited, it provides a starting point for understanding childhood cancer survivors’ health beliefs
and late effects screening practices grounded in a theory and evidence based perspective.
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CHAPTER I
INTRODUCTION
In the United States, an increase in incidents of childhood cancer has occurred in the last
22 years, from 15.7 cases per 100,000 children to 17.7 cases per 100,000 children (Howlader, et
al., 2015). Improvements in the treatment of childhood cancer have enabled many childhood
cancer patients to live well in to adulthood (American Academy of Pediatrics, 2009).
Unfortunately, the majority of these childhood cancer survivors develop at least one long-term
side effect, known as a late effect, from their initial cancer treatment (Howlader, et al., 2013).
Chapter One will discuss the prevalence of childhood cancer, what childhood cancer is,
and how it is treated, what late effects are and the types of late effects, the impact of late effects,
the importance of screening for late effects, and what researchers know about childhood cancer
survivors participation in screening for late effects. The end of Chapter One presents the purpose
of the study, the research questions asked, definition of terms used throughout the body of this
work, an introduction to the theoretical framework upon which the study was built, and the
importance of the study.
Background
According to estimates from the National Cancer Institute (2014), more than 15,780
children between the ages of 0 -19 were diagnosed with cancer in 2014. The number of
diagnoses is steadily increasing at a rate of 0.6% each year (Smith, et. al., 2010). Approximately
one in 300 boys and one in 333 girls are diagnosed annually (Howlader, et al., 2009). Compared
to white children, African American children have a 28% reduced risk of developing a childhood
cancer and Asian, and Hispanic children have a 15.5% reduced risk (Chow, et al., 2010). While
childhood cancer is rare, it is the second leading cause of death for children who have lived past
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infancy (National Cancer Institute, 2014). Yet the prognosis for childhood cancer patients is
improving. Surveillance Epidemiology and End Results Program (SEER) estimates that there are
currently 328,652 adult survivors of childhood cancer in the United States, which comprises
0.1% of the adult population. (Maeda, 2009; Mariotto et al., 2009).
Childhood Cancer
Cancer is a term used to describe multiple diseases in which mutated cells divide in an
uncontrolled manner and invade the surrounding tissues and organs rapidly and without
restriction (NCI, 2015). These cells take advantage of the immune system to survive and
continue to replicate and invade healthy portions of the body. Childhood cancers differ from
adult cancers in the types of cancer, drugs used for treatment, and even how patients respond to
treatment both short and long-term. Unlike most adult cancers, which are caused by mutations of
genes associated with exposure factors such as ultraviolet (UV) light, asbestos, tobacco or other
carcinogens, most childhood cancers stem from genetic mutation in a child’s DNA early in life
often before birth (American Cancer Society, 2016). Less than five percent of childhood cancers
are cause by inherited gene mutations (National Cancer Institute, 2014).
There are 12 common types of childhood cancers of which, leukemia (blood cancer) and
tumors are the most common with acute lymphoblastic leukemia (ALL) and brain tumors being
the most common of the two respectively (Howlader, et al., 2013). Of the children diagnosed
with cancer each year, one out of five is expected to die within the first five years of their
diagnosis (Howlader, et al., 2013). However, the prognosis for childhood cancer patients is
improving. Over the last 20 years, the five-year survival rate for childhood cancer patients has
dramatically increased from nearly incurable to over 80% (Maede, 2008). The increase in
survival rate has been attributed to improvements in how childhood cancer is treated.
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Childhood Cancer Treatment
Most childhood cancer patients are treated at a childhood cancer facility or hospital
associated with the Children’s Oncology Group (COG) supported by the National Cancer
Institute. COG is the largest organization in the world dedicated to treating childhood cancer;
facilities associated with COG must meet strict standards for treatment and care (NCI, 2015).
Childhood cancer treatment modalities vary based on diagnosis, but for children the most
common forms consist of either one or more of the following modalities; surgery, chemotherapy,
radiation therapy, and stem cell transplants (American Cancer Society, 2016).
Surgery is predominately used to remove solid tumors from a specific location, but can
also be used to de-bulk/reduce the size of a tumor if removal is not possible due to risks, or to
alleviate symptoms associated with the cancer (NCI, 2015). Surgery is most often used in
conjunction with another form of treatment such as chemotherapy or radiation therapy.
Chemotherapy also referred to as “chemo,” is a series or combination of drugs used to
treat or alleviate symptoms of cancer (NCI, 2015). The specific drugs used for chemotherapy, the
amount, and quantity of doses a patient receives depends on the specific type of cancer a patient
is diagnosed with. Since childhood cancers differ from adult cancers the types of chemotherapies
used, the dosage levels, and frequencies differ from those used to treat adult cancers.
Chemotherapy is used to attack fast growing cells, however in children, all cells are fast
growing, so chemotherapy often kills both the cancerous cells as well as other cells in the body
including those of the immune system (NCI, 2015). Chemotherapy can have a number of
immediate side effects such as low blood counts; nausea, hair loss, diarrhea, these and other
immediate side effects depend on the type and strength of chemotherapy. Chemotherapy can be
used alone or in conjunction with surgery or radiation therapy (NCI, 2015).
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Radiation therapy is another treatment modality that can be used alone, or in conjunction
with another form of cancer treatment. Radiation can slow or terminate a cell’s growth, including
both cancer and neighboring tissue or organ cells. External radiation is used to address a targeted
area, while internal radiation is given intravenously and seeks out cancer cells internally (NCI,
2015). The type of radiation and location impacts the types and intensity of side effects cancer
patients experience from fatigue to infertility.
Stem cell transplants are used in conjunction with either chemotherapy or radiation
therapy. Chemo or radiation is used in high doses to eliminate cancerous cells as well as healthy
cells. Stem cells are then transplanted to combat cancerous cells, or to help build red and white
blood cells, so that they can help a patient recover from chemo or radiation therapy (NCI, 2015).
Childhood Cancer Survivorship
An individual is considered a childhood cancer survivor from the time they are diagnosed
with cancer until the end of their life (NCI, 2015). For childhood cancer patients a new term,
long-term cancer survivor, is being used to distinguish survivors who are five years post final
cancer treatment and those who are recently diagnosed or being treated. Survivorship is filled
with a variety of new changes for a childhood cancer survivor and their family, including
excitement around completing treatment, developing a new sense of what “normal” life is like,
and navigating aspects of long term follow-up care as well as the necessary screenings to
monitor for late effects.
Late Effects
Treatment of cancer can cause immediate side effects such as low blood cell counts, hair
loss, nausea, diarrhea, or other complications, but it can also cause side effects that develop well
after the initial treatment phase. Late effects, defined by the National Cancer Institute as, “a
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health problem that occurs months or years after a disease is diagnosed or after treatment has
ended” and have serious effects on the health of survivors (2016). For childhood cancer patients
it is extremely important to be aware of the late effects associated with the modalities used to
treat the cancer patient’s initial diagnosis.
Statement of the Problem
Significant advancements in the treatment of childhood cancers have helped to increase
the five-year survival rate from 56% in the early 1970s to approximately 80-85% in the early
2000s (Greenlee, Murray, Bolden, & Wingo, 2000; Hampton, 2005). It is estimated that there are
currently 380,000 childhood cancer survivors in the United States, which is approximately 1 in
1,000 adults (Ward, DeSantis, Robbins, Kohler, & Jemal, 2014). As the number of childhood
cancer survivors continues to increase, physicians and researchers have been able to study and
identify the varying impacts cancer treatment has on the health of childhood cancer survivors.
The majority of childhood cancer survivors (60% to 90%) will develop some form of long-term
chronic condition due to their treatment and up to 40% of these late effects will be lifethreatening (Howlader, et al., 2013).
The type, and intensity of health-related late effects are associated with diagnosis,
treatment type (chemotherapy, radiotherapy, or both), treatment dosage and duration, gender, age
at diagnosis, and treatment location. In a study using data from the National Childhood Cancer
Survivors Study (CCSS) (Hudson, et al., 2003) found that demographic and treatment variables
were associated with the adverse health-related outcomes of childhood cancer survivors. The six
health domains measured were, general health, mental health, functional status, limitations of
activity, pain as a result of the cancer or its treatment, and anxiety/fears as a result of the cancer
or its treatment (Hudson, et al., 2003). Among survivors and their siblings, the prevalence of

6
adverse health outcomes in one of the six domains was associated with being female, having an
annual household income of less than $20,000, and not completing high school (Hudson, et al.,
2003). Being female, was associated with reporting at least one adverse health outcome, in all
domains except for pain (Hudson, et al., 2003).
Type of cancer also played a role in the number of adverse health-related outcomes
survivors reported post treatment. Survivors, who had central nervous system tumors, as well as
bone tumors, reported more adverse health outcomes in functional status, activity status, and
general health compared to survivors of leukemia (Hudson, et al., 2003). Type of treatment was
also found to be associated with reporting more than one adverse health outcome; again
survivors of central nervous system and bone tumors (often treated with surgery, radiation
involving the head/brain, chest/mantle, or alkylating agent chemotherapy) were twice as likely as
leukemia survivors to report adverse health outcomes (Hudson, et al., 2003).
To aid in the detection of late effects, the Children’s Oncology Group (COG), has
established a recommended late effects screening protocol for childhood cancer survivors.
COG’s protocol is based on a patient’s cancer diagnosis, level of exposure to specific drugs, and
the risk associated with developing specific late effects (Landier et al., 2004). Oncologists,
nurses, and other clinicians treating childhood cancer patients and survivors developed these
risk-based screening protocols based on evidence and practice experience. Many of the screening
protocols can begin as soon as two years after the end of treatment but are separate from followup care of the initial cancer diagnosis (Landier et al., 2004).
While the majority of young adult survivors of childhood cancer are at risk for
developing a late effect, most are not participating in recommended screening protocols to
identify late effects (Schultz et al., 2010). In a study conducted among 335 Swedish childhood
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cancer survivors, researchers found that 60% of survivors of acute leukemia, lymphoma, or
Wilms’ tumor, who were surveyed about their attendance at follow-up clinics or appointments,
reported not having a follow-up appointment scheduled, even though 50% reported having
negative symptoms related to their original cancer treatment (Arvidson, Söderhäll, Eksborg,
Björk, & Kreuger, 2006). Nathan et al. (2009) found that among patients with a higher risk for
developing cardiology problems or breast cancer because of the cancer treatment they received,
only 28% susceptible to cardiology problems, and 41% susceptible to secondary breast cancer,
participated in the recommended screening protocol for detection of these late effects. While
healthcare providers and researchers are becoming more aware what late effects childhood
cancer survivors are likely to develop, and which demographic characteristics of a childhood
cancer survivor are associated with their likelihood to attend an appointment to screen for late
effects, little is known about which behavioral factors influence childhood cancer survivors’
decisions to participate in late effects screening.
Purpose of the Study
The purpose of this study is to examine young adult survivors of childhood cancer
participation in screening for late effects by: 1) identifying non-modifiable factors associated
with young adult survivors of childhood cancer’s participation in screening for late effects; 2)
identifying modifiable factors associated with young adult survivors of childhood cancer’s
participation in screening for late effects; and 3) examining the relationship between identified
factors and subsequent screening for late effects. The purpose of this study drives the three main
research questions.
Research Questions
The following research questions were used to guide this study:
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1. What factors are associated with young adult survivors of childhood cancers participation
in screening for late effects?
a. What are the non-modifiable factors associated with young adult survivors of
childhood cancer’s participation in late effects screening?
b. What are the modifiable factors associated with young adult survivors of
childhood cancer’s participation in late effects screening?
2. What is the relationship of modifiable factors to young adult survivors of childhood
cancer’s participation in late effects screening?
3. Can the Health Belief Mode be used to explain behavior of young adult survivors of
childhood cancer as it relates to screening for late effects?
Theoretical Perspective
The conceptual framework for this study incorporates two theoretical perspectives; the
Health Belief Model (HBM) and grounded theory. The HBM is the primary theory underlying
this proposed study; it links an individual’s values and expectancy to a health-related behavior.
The major conceptual components assess an individual’s perception of the severity of an illness
and the individual’s perception of their susceptibility to developing that illness. It assesses the
individual’s perceived benefits of a specific health behavior and the perceived barriers the
individual must overcome to participate in the behavior. These perceptions influence an
individual’s behavioral intention, which is closely linked to whether or not an individual
participates in a specific health behavior. The first phase of this study utilized the HBM.
Using the HBM, if a survivor perceives themselves to be susceptible to developing late
effects; perceives late effects to be severe enough; believes the benefits for screening for late
effects outweigh the barriers to screening for late effects; and cues to action arise, then a survivor
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may take action in screening for late effects. For this study, selected constructs were combined to
form the independent variables. The HBM was central to assessing the relationship between
these variables and a survivor’s intent to participate in screening for late effects. However, since
only a few studies (Lupatsch, et. al., 2016; Michel, et. al., 2010) have utilized the HBM to assess
childhood cancer survivors’ participation in late effects screening, a grounded theory approach
was used to supplement known quantitative measures.
During the second phase of the study a modified form of grounded theory was utilized to
assess responses to supplemental qualitative interviews. In the late 1960s Glaser and Strauss
developed grounded theory while undertaking the research study Awareness of Dying (1965).
During the development of this theory, they emphasized the need to create theories that emerged
from, and coincided with social research. They believed this method is “more successful than
theories logically deduced from a priori assumptions” (Glaser & Strauss, 1967, p. 6). Glaser and
Strauss stressed that the importance and function of ground theory is to discover an underlying
theory that emerges from the systematic review of data (Kenny & Fourie, 2014). Grounded
theory sets out a methodological procedure for developing a theory through the use of:
theoretical sampling and coding, constant comparison, saturation, and memo writing, are used
throughout the three stages of coding.
Operational Definitions
There are varying definitions for the terms that will be used throughout the remaining
chapters. For the purpose of this study the following definitions of terms were used.
Childhood cancer. Any cancer diagnosis as early as birth to as late as 18 years of age will be
considered to have been childhood cancer.
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Childhood cancer survivor. Any individual diagnosed with a childhood cancer that has
completed treatment for their cancer diagnosis and is five years out from their last treatment is
considered a childhood cancer survivor.
Young adult. An individual who is between the ages of 18 and 29 years of age.
Late effects. A physical or mental health condition associated with the treatment of a childhood
cancer that has developed.
Non-modifiable factors. Factors that cannot be changed.
Gender. The set of characteristics that distinguishes man from woman.
Education. The level of formal learning from elementary school through post-secondary
education.
Income. The total financial earnings of a family in the past year.
Age. The numerical measure of time in years. Study participants between the 18 and 29
years old.
Age at diagnosis. The age when the participant was diagnosed with cancer.
Diagnosis. The type of cancer the participant was initially identified as having during
childhood.

Modifiable factors. Factors that can be influenced or changed.
Health Belief Model Constructs. Six factors, known as constructs, are combined to create the
Health Belief Model.
Perceived severity. A person’s beliefs about the impact a particular health condition
could have on them if a particular behavior is not implemented (Janz, Champion, & Strecher,
2002). When a survivor believes that late effects are serious enough to require early intervention.
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Perceived susceptibility. A person’s belief about how likely it is for them to develop a
particular health condition (Janz et al., 2002). A survivor’s belief about how likely they are to
develop a late effect.
Perceived barriers. A person’s belief that certain obstructions are keeping them from
completing the recommended health behaviors (Janz et al., 2002). A survivor’s belief that there
are things keeping them from screening for late effects.
Perceived benefits. A person’s belief that participating in a health behavior will reduce
their health risk (Janz et al., 2002). A survivor’ belief in that screening for late effects will be
effective in reducing the risks associated with late effects.
Cues to action. Triggers that activate a person to take action (Janz et al., 2002). Specific
thoughts or experience that will trigger a survivor to make or attend a late effects screening
appointment.
Self-efficacy. A person’s confidence in their ability to complete an action (Janz et al.,
2002). Survivors’ confidence is their ability to find a location for late effects screening, to
schedule and attend a late effects screening appointment.
Importance of the Study
Current research has focused primarily on demographic and non-modifiable factors
associated with a childhood cancer survivors’ participation in late effects screen. Factors such as
race, knowledge about treatment, barriers to care, and time since treatment, which have been
found to be associated with childhood cancer survivors’ non-participation in late effects
screening. In a study that compared the late effects screening compliance of minorities to those
of Caucasians, African Americans reported better preventative practices than all other races and
African American females had the highest compliance rate for late effects screening (Castellino
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et al., 2005). A survivor’s knowledge about their cancer treatment and their level of concern for
their overall health has also been associated with their participation in late effects screening
(Yeazel, 2004; Oeffinger, 2006) along with a lack of barriers to care (Park, et al., 2005).
Although, the underlying purpose of the studies that identified these factors was not to identify
modifiable or health belief factors that could be influenced through targeted program
components. While the results of previous studies can be used to help predict which survivors are
more likely to participate in late effects screening they do not provide insight on the beliefs or
motivating factors that influence a survivor’s decision to participate in late effects screening.
Chapter two will present a view of the available literature on the impact of childhood
cancer treatment, screening for late effects as a form of health promotion, and the current
literature that identifies non-modifiable factors associated with childhood cancer survivor’s
participation in late effects screening. Additionally, late effects screening practices of other
cancer populations, and how the HBM has been used to understand cancer-screening practices of
other populations will be discussed.
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CHAPTER II
LITERATURE REVIEW
Little is known about the modifiable factors influencing the late effects screening
practices of young adult survivors of childhood cancer. Research has primarily focused on
identifying the specific late effects associated with treatment protocols and assessing the rates of
childhood cancer survivors’ participation in late effects and secondary malignancy screening
behaviors. To date, studies have identified non-modifiable factors such as demographic and
treatment factors associated with childhood cancer survivors’ participation in screening for late
effects, but have not identified modifiable factors such as why childhood cancer survivors
participate in late effects screening or what factors influence their decisions to screen for late
effects. Chapter Two will describe the impacts of childhood cancer treatment, screening for late
effects, late effects screening as a form of health promotion and prevention, the Health Belief
Model as a theory to explain late effects screening practices.
Impact of Childhood Cancer Treatment
Childhood cancers affect patients in a variety of ways. Immediate side effects of
treatment, such as nausea, hair loss, fatigue, loss of appetite, and other reactions to treatment are
the most commonly known impacts. However, lesser known impacts include the financial costs
of treatment, both direct and indirect and the long term side effects, known as late effects that
develop months, years, and even decades after treatment for cancer is complete.
The cost of treating childhood cancer has been measured in many different ways. Two
distinct categories can be used to classify these types of measurements; direct and indirect costs.
Direct costs, are the financial expenses incurred covering the cost of treatment and secondary
conditions caused by chemotherapy or radiotherapy. Indirect costs are the financial deficits
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survivors incur, such as loss of earning, or educational attainment compared to their non-cancer
peers.
Direct Costs
Researchers have worked to quantify the financial cost of childhood cancer treatment. A
study conducted in the early1980s in the United States, found that the average cost of childhood
cancer treatment alone ranged from $8,000 to $53,000 (accounting for inflation this would be
approximately $20,592 to $136,427 in 2019) depending on the type of cancer (Lansky, Black, &
Cairns, 1983). Lansky et al. (1983) found that the majority of charges were due to inpatient care,
that more than 50% of costs were incurred in the diagnostic and terminal stages of treatment and
that insurance coverage does not cover the full amount needed for treatment. In the United
Kingdom, researchers measured income loss of family members (primarily mothers who left
fulltime positions to care for their child with cancer), as well as expenditures above that of the
normal family expense. Eiser and Upton (2007) found that 34% of mothers who had fulltime
employment quit their jobs to care for their child and that the household expenditures increased
on average from £50–100 (approximately $69US –$138US) in the areas of travel, food, phone
calls, gifts/ treats for the child and siblings, health food, clothing, childcare for siblings, home
help, and accommodation. A cross sectional survey of parents who were caring for childhood
cancer patients measured the extra costs incurred over the 30 days prior to the survey as a result
of their child being in treatment. Dockerty, Skegg, and Williams (2003) found that on average
13% of the family’s income was spent on extra expenses such as increased electrical bills,
parking and transportation costs, and an increase in medication and food expenditures.
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Indirect Cost
Indirect costs to survivors and their families can vary from unexpected extra expense to
loss of educational and job attainment. A major financial concern for survivors of childhood
cancer is their ability to obtain health insurance as adults. Prior to the Affordable Care Act
childhood cancer survivors faced difficulty trying to obtain healthcare through employer plans
and if they were able to obtain coverage, even with their preexisting condition, they were and are
still, at risk for facing higher premiums (Park et al., 2005). Survivors of childhood cancer also
reported less insurance coverage than their siblings; with 23% of survivors compared to 3% of
siblings reporting difficulty in obtaining health insurance. Survivors of childhood cancer were
also more likely to have public insurance than their siblings (Park et al., 2005).
Survivors of childhood cancer are also at risk for lower educational and job related
success than their siblings and peers. According to a study conducted using data from the CCSS,
23% of survivors compared to 8% of their siblings used special education services in school,
those survivors who did not utilize these services were at a greater risk for not completing high
school or doing as well as their peers who did utilize these services (Mitby et al., 2003). Another
study conducted using data from the Childhood Cancer Survivors Study established three
occupational categories Managerial/Professional, Nonphysical Service/Blue Collar, and Physical
Service/Blue Collar. Results from this study showed that compared to their siblings, childhood
cancer survivors were less often in higher-skilled Managerial/Professional occupations than their
siblings and within each of the categories survivors' personal income was lower than siblings
even after adjusting for socio-demographic variables (Kirchhoff et al., 2010).
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Late Effects
Not only are the direct and indirect costs of treatment impactful to childhood cancer
survivors, but childhood cancer survivors must also be aware of the physical and psychological
cost they incur due to treatment in the form of late effects. These late effects can vary from
delayed mortality to psychosocial issues.
Delayed Mortality. Survivors of childhood cancer are at a higher risk of mortality than
their peers and death is mainly due to their previous cancer, a secondary cancer, or a
noncancerous cause (Möller, Garwicz, Barlow, Winther, Glattre, Olafsdottir, G., Hulinius, 2001).
A retrospective study to assess the long-term risks associated with developing a secondary
malignant neoplasm, a secondary cancerous tumor, was conducted using data from 1,285 5-year
survivors of childhood cancer who were diagnosed between the ages of 20-24 in Great Britain.
Researchers found that females and survivors of CNS tumors had a higher risk of death than
male survivors or survivors of other cancers (Yang, Goddard, Spinelli, Gotay, & McBride,
2012). Survivors from Great Britain appeared to have a lower increase in mortality (six times
that of non-survivors) than survivors in the United States who reported a 10.8 fold increase in
mortality compared to their peers (Mertens, Yasui, Neglia, Potter, Nesbit, Ruccione, & Robison,
(2001). In a retrospective study of 5-year childhood cancer survivors in the United States
Mertens, et al. (2001) also found that females, those diagnosed with cancer before the age of
five-years, and those with an initial diagnosis of leukemia or CNS tumor, had a statistically
significant higher risk of delayed mortality. These researchers also found that increased risk of
mortality was associated with cardiac, pulmonary, and other late effects (Mertens, et al., 2001).
Nervous System Complication. The nervous system is the most common system/organ to
be impacted by the treatment modalities of childhood cancer, occurring in 27% of survivors
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(Skinner, 2012). The nervous system manages both the voluntary and involuntary functions of
the body. Neurotoxicity is primarily found among survivors of CNS tumors as a consequence of
cranial radiotherapy, or chemotherapies targeted at CNS tumors and can cause damage from
delayed or lost motor functions to cognitive problems (Skinner, 2012).
Hearing, Speech, and Vision Late Effects. Over 12% of childhood cancer survivors
report some form of sensory loss related to their initial cancer treatment (Skinner, 2012). Hearing
loss, can lead to speech and educational delays, especially in younger survivors. A common lateeffect of retinoblastoma and orbital rhabdomyosarcoma, cancers that appear in or near the eye
and require radiotherapy, are cataracts (82%) and decreased vision (70%) (McDowell, 2008).
Endocrine System Complication. The endocrine system complications are the second
most common late effects impacting 18% of childhood cancer survivors (Kopp, Gupta, PelayoKatsanis, Wittman, & Katsanis, 2012). Hypothyroidism is the most common of the late effects of
the endocrine system, in conjunction with it, survivors’ decreased ability to metabolize glucose
and their developed insulin resistance, can lead to obesity (Kopp, et al., 2012).
Reproductive late effects. Both male and female reproductive abilities are impacted by
chemotherapy and radiotherapy. Chemotherapy and radiotherapy are known to cause delayed
puberty or early onset puberty among children (Skinner, 2012). Damage to germ cells for both
males and females are impacted by the lowest levels of radiation and lowest doses of
chemotherapy; for males this can result in a decrease in the amount of testosterone and sperm
produced and in females it can result in a decrease in the production of eggs (Skinner,
2012). Due to advancements in chemotherapy treatments, males who were at a greater risk of
decreased sperm and testosterone production can usually recover to normal production levels 18
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months after the completion of treatment (Viviani, Santoro, Ragni, Bonfante, Bestetti, &
Bonadonna, 1985).
Females who were treated with radiation in the thoracic region, as well as, those treated
for Hodgkin’s Lymphoma were at a greater risk (12-20%) of developing breast cancer compared
to the general public (Yang, et al. 2012). Age at treatment is one of the most important risk
factors for premature ovarian failure, the older the patient is at diagnosis the greater the risk for
ovarian failure (Botha & Kruger, 2012). Girls who receive pelvic or abdominal irradiation or
who receive total body irradiation, the removal of bad tissues from bone marrow, are at a greater
risk for miscarriage, intra-uterine growth restriction and premature delivery (Green, Hall, &
Zevon, 1989).
Psychosocial Late Effects. Measuring the psychosocial late effects of cancer treatment
has been a challenge for researchers over the last two decades. Psychosocial late effects
associated with health issues are often measured using quality of life (QOL) tools as it has
become a way to measure individuals overall well-being, incorporating mental, physical, and
social health. However, QOL tools for childhood cancer survivors have only recently been
developed, and their success at measuring the physical and psychosocial well being of survivors
is still up for debate.
The use of harsh treatments have led to the development of late effects, at an increasing
rate of 0.5% with a cumulative predicted rate of 25% within the next 50 years (Varan & Kebudi,
2011). Among childhood cancer survivors, late effects have become the second leading cause of
death (Mertens et al., 2001). While a majority of young adult survivors develop late effects, most
are not participating in the screening activities necessary to identify and treat late effects (Schultz
et al., 2010).
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Screening for Late Effects
Childhood cancer used to be treated as an illness that was either curable or terminal, but
now as childhood cancer survivors live longer, they should be transitioning from cancer care into
a new phase that is focused on identifying and treating the late effects of treatment known as
survivorship care. Like many health issues, early detection of a late effect can impact the course
of treatment (NCI, 2017).
In 2003, the COG published their first set of risk-based recommendations for screening
for late effects in Group Long-Term Follow-Up Guidelines for Survivors of Childhood,
Adolescent, and Young Adult Cancers. For each treatment modality, the strength of the drug or
radiation, the quantity and frequency and total number of doses is considered in conjunction with
the available evidence that connects the treatment with an adverse health outcome. A panel of
experts then developed the recommendation for appropriate screenings and intervals for
screening. The most recent version of the guidelines was published in 2013, is over 200 pages in
length, and technical in language. To better equip survivors with knowledge about screening and
late effects the COG developed shortened educational documents for survivors called Health
Links. Yet very few childhood cancer survivors are participating in late effects screening.
Childhood Cancer Survivors Participation in Late Effects Screening
Non-Modifiable Factors Associated with Late Effects Screening
Current research on childhood cancer survivors and their participation in late effects
screening has focused on a number of factors that are non-modifiable. The non-modifiable
factors that researchers have found to be associated with childhood cancer survivors participation
in late effects screening include, gender, ethnicity, age, socio-economic status, and treatment
modality.

20
Gender. A childhood cancer survivor’s gender is associated with participation in late
effects screening behaviors. Male childhood cancer survivors have reported less participation in
late effects screening compared to their female counterparts (Oeffinger, et. al., 2004). Uninsured
males reported significantly fewer visits to physicians’ offices for cancer-related visits, than
other males and women (Oeffinger, et. al., 2004). Female childhood cancer survivors who
received hematopoietic cell transplants as part of their bone marrow transplant were more likely
than their male counterparts to participate in screening for a late effect (Armenian, Sun,
Francisco, Baker, Weisdorf, Forman, & Bhatia, 2011).
Ethnicity. The role ethnicity plays in childhood cancer survivors participation in late
effect screening has not been solidified. Oeffinger et. al. (2004) assessed the childhood cancer
survivor’s attendance at cancer related physician appointments and found no significant
difference in ethnicities or minorities attendance to a cancer-related physicians appointments. A
study that used a subset of the data from the CCSS, aimed at assessing the healthcare use of
minorities, found non-Hispanic blacks and Hispanics, utilized the same amount of cancer-related
services as whites (Castellino, et. al, 2005). Hispanic male and female childhood cancer
survivors reported more use of cancer-related physician services compared to white survivors
and African American females reported higher compliance levels with late effects screening
recommendations compared to whites, Hispanics, and their male counterparts (Castellino, et. al,
2005).
Age. Age is another demographic factor associated with participation in screening for late
effects. Half of the childhood cancer survivors between the ages of 18 and 24 surveyed as part of
the CCSS reported attending a cancer-related visit with a physician; as time from treatment and a
survivor’s age increased, the proportion of childhood cancer survivors attending visits related to
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their initial cancer diagnosis decreased (Oeffinger et. al., 2004). Among survivors of acute
leukemia, lymphoma, and Wilm’s tumor, age was associated with participation in an
appointment to screen for late effects, the younger a survivor was the more likely to attend an
appointment (Arvidson, et. al., 2006). For childhood cancer survivors in Sweden, being younger
was associated with attending a late effects follow up appointment (Michel, et. al., 2010).
Socio-Economic Status. Lower socio economic levels are also associated with lack of
participation in screening for late effects. Casillas, et. al. (2015) found that childhood cancer
survivors earning less than $20,000 a year and having less than a high school degree, were
independently associated with not attending an appointment for follow-up care related to initial
cancer treatment. Childhood cancer survivors at risk for secondary cancers, were more likely to
screen for breast cancer, colorectal cancer, and skin cancer if they had a college degree or higher
(Nathan, et. al. 2010). Among childhood cancer survivors in Sweden, Michel, et. al. (2010)
found being unemployed with a lower educational background was associated with attending a
late effects follow up appointment, the opposite for American childhood cancer survivors.
Diagnosis. Survivors of Hodgkin’s disease are at a higher risk for developing late effects
than other childhood cancer survivors and while a greater percentage reported attending more
appointments related to their initial cancer than their peers who were at a lower risk of a
developing a late effect, 50% still reported not attending any type of physician appointment in
the past two years (Oeffinger, et al. 2004). Nathan et. al. (2010) found that female survivors of
childhood cancer who were at an increased risk of breast cancer reported lower levels of
adherence to screening protocols (46%) than survivors at a lower risk of breast cancer (67%).
Treatment modality. Childhood cancer survivors who received treatment that placed
them at a higher risk for developing a late effect reported attending more physician visits than
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their childhood cancer peers who were at a lower risk, however their attendance at physicians’
visits to screen for late effects decreased with age and time from treatment (Oeffinger, et. al,
2004). Similarly, childhood cancer patients treated with high levels of anthracycline are at a
greater risk for developing heart abnormalities (Lipshultz, et. al., 1995). Of the childhood cancer
survivors treated with levels of anthracyclines likely to cause cardiomyopathy only 51% reported
attending a cancer related physician’s appointment in the past two years (Oeffinger, et. al. 2004).
Survivors of childhood cancer who received a bone marrow transplant were also more likely than
their fellow childhood cancer survivors to report attending a cancer-related physician’s visit to
follow-up or screen for late effects (Bishop, et. al. 2010).
Knowing which non-modifiable risk factors are associated with a childhood cancer
survivor’s participation in late effects screening can only provide healthcare professionals
working to transition survivors from treatment to screening with enough information to identify
the survivors who may or may not screen for late effects. In order to understand and explain how
childhood cancer survivors decide to participate in late effects screening and create health
promotion programs for this population we need to know what modifiable factors influence a
childhood cancer survivor’s decision to screen for late effect.
Screening for Late Effects as a Form of Health Promotion and Prevention
The main focus of health promotion and prevention programs is to get people healthy and
keep them healthy. With the advancements in cancer treatment resulting in increased survivor
rates, focus is shifting from curing patients to keeping them healthy with the use of health
promotion and prevention strategies that will help them to detect late effects. Rowland (2008)
lays out seven compelling reasons why health promotion is needed as part of cancer
survivorship: (1) there are more cancer survivors now than ever before, (2) these survivors are
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living longer, (3) survivors are at a greater risk for comorbidities complicated by previous cancer
diagnosis, (4) treatments used to cure cancer can compromise a survivor’s health in many ways,
(5) early intervention has the ability to reduce death and lessen the morbidity associated with
cancer (6) survivors are requesting and are more interested in information on proper care post
treatment (7) cancer as a life-threatening illness has such a profound effect on many people’s
lives that it is teachable moment. Healthcare providers including doctors, nurses, and social
workers are working to transition childhood cancer survivors from treatment to screening for late
effects, with screening practices starting as early as two years post treatment.
Over the years multiple theories have been developed to understand and explain how
individuals make decisions associated with health behaviors, and what factors can be targeted to
influence these decisions. The Health Belief Model is one of the most widely applied
frameworks used to understand and influence modifiable health behaviors at the individual level
(Janz, et. al., 2002). The development and modifications of the HBM will be briefly discussed in
the next section, as well as, the application of the constructs of the HBM to childhood cancer
survivors’.
Health Belief Model
The Health Belief Model was originally developed to explain the behavior of individuals
who did not participate in free tuberculosis health screening in the 1950s by Hochbaum,
Leventhal, Kegeles and Rosenstock (Janz, et. al., 2002). The theory’s five major constructs are:
(1) perceived susceptibility, an individual’s assessment of their likelihood to develop the
condition; (2) perceived severity, an individual’s belief in the seriousness of the condition and
consequences; (3) perceived barrier, an individual’s assessment of the potential factors that
discourage or impede the adoption of a specific behavior; (4) perceived benefits, an individual’s
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belief in the positive outcomes associated with adopting a particular behavior; and (5) cues to
action, an individual’s readiness to take a health action or incentive to live a healthy life-style
(Janz, et. al., 2002). The construct of self-efficacy, an individual’s belief in their ability to
successfully take action towards the adoption of the behavior, was later added Rosenstock,
Stretcher, and Becker in 1988 as a separate construct (Champion & Skinner, 2008).
Modifying Factors

Individual Beliefs
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Gender

Perceived
Threat

Perceived
Severity

Ethnicity
Personality
Socioeconomics
Knowledge

Actions

Perceived
Benefits

Individual
behaviors

Cues to Action

Perceived
Barriers
Perceived
Self-Efficacy

Self Efficacy – Added to the Health Belief Model in 1988
Cues to Action
Figure 1. Health Belief Model Components Adapted from Champion and Skinner (2008).

Since its initial inception the Health Belief Model has been used to understand numerous
health screening behaviors, including screening for cancer in the general adult population as well
in the adult cancer survivor population. In order to measure the constructs of the HBM and if and
how they influence an individual’s behavioral intentions, a measurement tool was needed.
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Champion developed the most widely implemented tool that uses the health belief model to
assess screening behaviors of cancer survivor.
Champion pioneered the development of a questionnaire, the Health Belief Model Scale,
that related breast cancer screening with the constructs of the Health Belief Model and continued
to develop a valid and reliable tool that measured the constructs of health motivation,
susceptibility, benefits, and barriers (1984; 1999), and self-efficacy (Champion, Skinner, &
Menon, 2005) as they relate to breast cancer screening behaviors.
In a study conducted among women 35 years of age and older, using Champion’s Health
Belief Model scale, perceived barriers, benefits, susceptibility, health motivation (a measure of
cues to action) and confidence and control (measures of self-efficacy) were all found to be
associated with a women’s participation in a self-breast exam (Champion, 1990). Similarly,
among women screening for cervical cancer using Pap smear tests, 45.79% of the variance in
screening behaviors could be explained by the five factors of the health belief model, benefits,
barriers, motivation (cues to action), seriousness (severity), and susceptibility, over 15% of the
variance was explained by benefits (Guvenc, Akyuz, & Açikel, 2011). Adding cost, fatalism,
preference for female health professional, and the distance from the healthcare center were valid
additions to the barriers construct (Guvenc, et. al., 2011). Among older Chinese adults screening
for colorectal cancer, perceived susceptibility, severity, perceived benefits, and perceived
barriers, and knowledge (a measure of self-efficacy) were associated with participation in
screening for colorectal cancer (Leung, Wong, & Chan, 2014).
While there are many differences between childhood cancers and adult cancers both in
treatment and the life-stage at which the patient is treated for cancer, both types requires lifelong
surveillance and screening to detect secondary cancers or other late effects. Wilkins and
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Woodgate (2008) completed a comprehensive review of literature that compared the screening
for secondary cancer practices of childhood cancer patients and adult survivors of cancer.
Screening practices for testicular, colorectal, cervical, and breast cancer were compared between
childhood and adult cancer survivors. Across the studies, the proportion of childhood cancer
patients at risk for developing breast cancer who participated in a clinical breast examination was
similar to adult survivors of breast cancer, yet fewer long-term survivors of childhood cancer
reported mammograms compared to adult breast cancer survivors (Wilkins & Woodgate, 2008).
While the late effects screening behaviors of childhood cancer survivors do not entirely mirror
the screening behaviors of adult survivors of cancer they are similar and a starting point for
understanding childhood cancer survivors’ late effects screening behaviors.
Health Beliefs of Childhood Cancer Survivors
The majority of studies that have identified HBM constructs associated with childhood
cancer survivors’ participation in late effects screening have done so in a piecemeal fashion.
Most studies have focused on one or two of the constructs of the HBM, rarely using the full
model.
Perceived Susceptibility. Using the data obtained from the CCSS, researchers analyzed
the screening behaviors of childhood cancer survivors in relationship to a wide variety of
demographical variables, such as age, race, and education level. They found that female
survivors, who reported lower levels of concern for their health (perceived susceptibility)
performed fewer mammograms than those who had higher levels of concern for their health
(Yeazel et al., 2004). The researchers also found that female survivors who had a higher risk of
developing breast cancer from treatment were more likely to complete breast self-exams and
receive mammograms compared to their counterparts less at risk, as well as being more likely to
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complete a self-exam than their siblings who had not gone through treatment (Yeazel et al.,
2004). Compared to females in this study, males reported a lower level of testicular screening
behavior. Unlike females who received radiotherapy in a region of their body that could be
associated with breast cancer, males in this study did not receive radiotherapy near their testicles.
Thus females in this study were more likely to be susceptible to the cancer they were screening
for as they received treatment that increased their risk of a late effect compared to their male
counterparts that were not at an increased risk. However, this study retrospectively, selected
questions from a large national survey in which the questions we not specifically designed to
measure the constructs of the HBM.
Using data from the same CCSS Nathan, et. al. (2010) assessed the screening behaviors
of childhood cancer patients at average risk for developing cervical or breast cancer and the
screening behaviors of childhood cancer survivors at increased risk for developing breast cancer,
cervical, colorectal, and skin cancer. A majority of the survivors at average risk for breast or
cervical cancer who reached the recommended screening age reported participating in a
mammogram (76%) or Papanicolaou smear (81%) (Nathan, et. al., 2010). There was no
association found between survivor’s level of participation in their screening behaviors and their
level of concern for their future health, which could suggest that the survivors’ had a lack of
perceived susceptibility to developing a second cancer (Nathan et al. 2010). Of the childhood
cancer survivors from the same study who were at a greater risk for developing breast, cervical,
colorectal, or skin cancer due to treatment modality, 46% reported receiving a mammogram,
11.5% reported a colonoscopy, and only 26.6% reported having an examination of the skin
cancer sites previously treated (Nathan, et. al, 2010). Again, this study retrospectively selected
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questions that were not specifically structured to measure the HBM constructs and only
investigated one of the constructs.
Using latent class analysis, Cox (2012) assessed responses from the Childhood Cancer
Survivors Study and found that three distinct survivor profiles arose and could predict health
behavioral intent to screen for late effects. The worried (30%) class was comprised of survivors
who reported the most health concerns, poor perceived health status, had greater cancer related
fears and anxiety and were more motivated by extrinsic factors (Cox, 2012). The collaborative
(55%) class of survivors had the most moderate concerns about their health while the selfcontrolling (26%) class demonstrated the least concern for their health (Cox, 2012). The worried
and collaborative childhood cancer survivors were more likely to have a cancer related
appointment compared to the self-controlling survivors and a greater percentage of worried
survivors (90%) had cancer-related appointments than collaborative (88%) (Cox, 2012). Worried
survivors may perceive themselves to be at greater risk for developing a late effect
(susceptibility) or perceive the severity of late effects require a cancer related appointment with a
physician.
Perceived Barriers. Insurance coverage has been studied among many populations as a
potential barrier to accessing needed healthcare, including among childhood cancer survivors.
Park, et al. (2005) used data from the baseline questionnaire from the 1994 Childhood Cancer
Survivors’ Study and the supplemental follow-up questionnaire from 2000 to examine the
incidence and predictors of childhood cancer survivors’ and their siblings’ access to insurance
and the challenges they had in obtaining coverage. The authors found that in the six-year period
between 1994 and 2000, both groups increased insurance coverage, patients increased from 83.9
% to 88% and siblings from 88.3% to 91% (Park et al., 2005). While a difference in insurance
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coverage between siblings exists, the difference is not statistically different; suggesting coverage
alone is not the primary barrier to follow-up care. This study did not consider whether or not
insurers denied coverage of specific tests needed to screen for late effects. Oftentimes tests
recommended to detect late effects, such as mammograms are covered for women of a certain
age group and may not be covered for younger women without proper documentation. In a study
conducted by Park et. al. (2005) the researchers did not address whether “insurance coverage”
included denied claims for tests needed to screen for late effects. However, other studies have
substantiated that survivors with and without insurance, are not seeking healthcare for concerns
related to their primary cancer diagnosis. (Nathan, et al., 2009).
Knowledge of treatment and late effects (measure of self-efficacy). Survivors’ lack of
knowledge of their diagnosis and treatment protocols has also been considered to be associated
with their lack of participation in screening for late effects. Kadan-Lottick et. al. (2002)
conducted a telephone survey of 635 childhood cancer survivors and found that 72% of
childhood cancer survivors could accurately report their diagnosis with precision, meaning they
could specifically name their exact form of cancer, while 19% were able to accurately, but not
precisely recall their diagnosis. This same study found that of patients treated with doxorubicin
or daunorubicin, chemotherapies known to cause heart problems, less than a third of patient’s
receiving those therapies could recall receiving them (33% and 8% respectively) (Kadan-Lottick
et. al, 2002). Similarly, a Canadian study, conducted almost 30 years ago, aimed at identifying
what factors were associated with a childhood cancer survivors’ acknowledgement of their
cancer treatment, found that among 1,928 survivors of childhood cancer, 81% were able to
identify that they were treated for cancer and 50% were able to recall the type of treatment
received (Byrne, Lewis, Halamek, Connelly, & Mulvihill, 1989). Survivors’ ability to recall that
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they were treated for childhood cancer, and what their diagnosis was, can only provide current
physicians with limited information about survivors’ risks for late effects and how to properly
screen for them. Since many childhood cancer patients are treated at a young age, recalling exact
drugs and dosages can be a struggle for young adult survivors of cancer and could indeed be
associated with their lack of participation in screening for late effects. To date no studies have
investigated perceived severity of developing a late effect or the perceived benefits of screening
for late effects.
All Constructs of the Health Belief Model. Only two studies to date have used the full
Health Belief Model to assess childhood cancer survivors’ participation in screening for late
effect. Sweden has conducted a nationwide long-term, large-scale, follow-up survey of childhood
cancer survivors who registered with the Swiss Childhood Cancer Registry (Michel, et. al.,
2010). Of the 1,487 survivors contacted 1,075 responded to the survey, with slightly more males
participating than females (Michel, 2010). Questions developed to measure the health belief
constructs of perceived severity, perceived benefits, perceived barriers, and cues to action using a
4 point Likert-scale, and susceptibility were assessed by requesting survivors mark on a 10cm
scale how likely they might experience a late effect in the next ten years (Michel, et. al., 2010).
All constructs of the Heath Belief Model were significantly associated with a survivors’
attendance at a late effects follow-up appointment specifically lower barriers to care, higher
perceived susceptibility, severity, benefits and cues to action (Michel, et. al., 2010). When
researchers accounted for medical characteristics only benefits, barriers and health value
remained significant (Michel, et. al., 2010). A follow-on study assessed adolescent survivors
(age 16-21) attendance at late effects follow up appointments using the same questions from the
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Swiss Childhood Cancer Survivors Study and found only perceived benefits and barriers to be
associated with attendance at follow-up appointments (Lupatsch, et. al., 2016).
Currently, no studies have assessed American survivors of childhood cancer late effect
screening behaviors utilizing the full Health Belief Model. The constructs of perceived barriers,
perceived susceptibility, and cues to action have been explored as part of different studies (Park,
et. al., 2005; Nathan, et. al., 2009; Yeazel et al., 2004; Nathan, et. al, 2010; Cox, 2012) but not as
a whole.
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Figure 2. Health Belief Model

The purpose of this study was to identify what modifiable factors are associated with
young adult survivors of childhood cancer decision to participate in screening for late effects
using the HBM as a starting point to understanding their health behaviors. With minimal
research investigating health behavior theories to understand late effects screening practices of
young adult survivors of childhood cancer additional qualitative data was collected to further
understand modifiable factors.
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CHAPTER III
RESEARCH METHODOLOGY
Introduction
This chapter describes the methods used to study the factors that influence young adult
survivors of childhood cancers participation in late effects screening behaviors. A mixedmethods concurrent explanatory design with two phases: quantitative and qualitative data
collection was used. Participants self-selected to participate in an online survey and chose to optin to a one-on-one audiotaped interview. The sections of this chapter describe the research design
and rationale for choosing the mixed-method design, study measures, data collection, and data
analysis.
Research Design
Mixed-Methods
A mixed-methods approach using a two-phase sequential exploratory design was
implemented. Brynman (2006) sets out 16 typologies of reasons for using a mixed-method
design, five of these were used to rationalize the mixed-methods for this study, and they include:
offset, completeness, explanation, unexpected results, and sampling. Available research presents
mixed results as to whether the Health Belief Model Scale explains young adult survivors of
childhood cancer’s participation in late effects screenings and at the time of this study no other
studies have identified modifiable or health belief factors influencing the late effects screening
practices of young adult survivors of childhood cancer. Using a mixed methods design that
collects quantitative data first followed by in-depth qualitative interviews helped to offset the
strengths and weakness of each approach and provided a method for selecting the qualitative
sample. With mixed results about the role HBM plays in young adult survivors of childhood
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cancer’s participation in screening for late effects, a mixed-method design enabled collection of
quantitative data to assess the role of the HBM and to collect additional data that provided a
more complete explanation of the variables. Data collected during the qualitative portion of the
study helped to both explain the results of the quantitative portion and understand the unexpected
results.
A mixed-method design allows qualitative and quantitative data to be used to supplement
and further understand the research questions posed. Limited research has attempted to assess the
modifiable factors that influence a childhood cancer survivor’s participation in late effects. The
limited numbers of studies that have attempted to identify modifiable factors have primarily
utilized portions of the HBM. However, these studies were not specifically designed to test the
constructs of the model (Yeazel et al., 2004) as the measurement tool was not created or
validated to measure the HBM and mixed results were reported (Michel, et. al., 2010; Lupatsch,
et. al., 2016).
Since the HBM was previously tested and some constructs were found to be associated
with childhood cancer survivors’ participation in late effect screening the HBM was selected as
the initial theory and as a starting point to identify a quantitative tool that would be able to
specifically assess the HBM constructs as they related to participation in late effects screening.
Champion’s Health Belief Model Scale [Appendix A] was developed to assess breast cancer
patients’ participation in breast examination and has been adapted for use among different cancer
populations (Guvenc, et. al., 2011; Leung, et. al., 2014; Oliver, et. al., 2011). Permission was
obtained from Champion [Appendix B] to modify her original scale for the purposes of this
study. In the first phase of the study an adapted version of the HBM scale [Appendix C] was
used among young adult survivors of childhood cancer. With little research conducted to assess
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the HBM or any other behavioral health theory as it relates to young adult survivors of childhood
cancer late effects screening behavior, a second qualitative phase with open-ended questions
implemented. Results from the second phase was conducted to either support the results of the
first phase or identify additional constructs that lead to a new model or the identification of a
more appropriate theory. Figure 1. diagrams the two phases of the study.
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Interviews
scheduled

Phase Two:
Qualitative Data
Collected and
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(Interviews)
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Figure 3. Diagram of Study Design

Study Measures
Target Population
The target population for this study was young adult survivors of childhood cancer
between18-29 years old and five years post treatment for cancer. Young adults are at a unique
time in their lives in which they are transitioning from the care and guidance of their parents to
living and caring for their own needs. This time is filled with numerous developmental tasks
including career identification and development, developing critical thinking and problem
solving skills while making important life course decision, forming significant relationships like
friendships and marriages (Beaty, 2002). These tasks while similar to those in other life stages
are unique to the young adulthood. Defining the exact age range in which these developmental
tasks occur has varied from as young as 16 to as old as 40. A shift in the age of those being
treated in pediatric settings in occurring with 3% of patients being over the age of 18 and some
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as old as 60 (Kinnear, & O’Toole, 2015). Most survivorship studies have defined young adult
survivors up into the late 20s and early 30s (Fern & Whelan, 2013; Patenaude & Kupst, 2005;
Bleyer, 2005; Bleyer et al., 2006; Rainusso, Wang, & Yustein, 2013). This time of transition can
be challenging to a young adult who is also not managing the transition of responsibility for
doctors’ appointments and the physical and emotional impacts treatment from cancer has had on
these young adults.
Aside from the challenges and hurdles young adult survivors experience transitioning
from youth to adulthood there are also gaps in services available for a young adult survivor.
Most childhood cancer survivors receive treatment and follow-up care at a children’s hospital.
During their young adult years they “age-out” or become too old to be treated at a children’s
facility. They must navigate not only the identification of a primary care physician, but take
charge of the necessary follow-up regimen to screen for potential late effects. Many primary care
physicians are unaware of the necessary screening these patients need to monitor for the late
effects associated with the treatment they received at an early age.
Sample Size
In order to obtain a power of .8 with significance of .05 the target sample size for the first
phase of the study should have been179 participants. After two years of data collection and
observing a decrease in the number of participants after each post in the different social media
forums and groups the researcher decided to close the study and have it serve as a pilot test. A
post-hoc power analysis was run comparing the 60% non-attendance rate at late effects
appointments of childhood cancer survivors, to the sample rate of 26%, with a sample size of 92
and an alpha of .05, the power calculation was 100%.
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Eligibility and Exclusion Criteria
The target population for this sample was long-term young adult survivors of childhood
cancer. For the purposes of this study a long-term young adult survivor of childhood cancer was
defined as an individual diagnosed with childhood cancer between the ages of 0 - 18, a minimum
of five years out since date of last treatment, and was between the ages of 18 and 29 years old.
Pediatric cancer survivors who were five years off treatment for their initial diagnosis, but were
actively receiving treatment for a secondary cancer were excluded from the study. Survivors who
were not residents of the United States or using the United States healthcare system were
excluded from the study as well.
Setting
The quantitative portion of this study was conducted using an online survey and took
place in the location of the participant’s choosing. The qualitative portion of this study was a
series of in-depth questions that took place over the phone in the location of the participant’s
choice.
Recruitment Strategy
A convenience sample was used to recruit participants in both phases of this study.
Reaching long-term young adult cancer survivors to understand their screening behavior has
proved challenging. Survivors in this age rang are also members of the millennial generation, of
which, a majority (85%) report that they use at least one form of social media (Jiang, J., 2018).
During Phase One of the study a targeted distribution of surveys using social media
outlets was utilized. There are numerous online resources and communities available for young
adult survivors of childhood cancer, from blog sites to Facebook support groups. Recruitment
began by partnering with the Association of Pediatric Oncology Social Workers (APOSW). The
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APOSW is the professional association for social workers and other allied health professionals
who provide support and treatment to children and young adults with cancer and their family
members. Members of the APOSW self-selected to share a link for the online survey on
Facebook and survivorship pages, as well as group pages supported by APOSW members.
After eight weeks, the response rate was 20 participants. An internet search was
conducted and additional organizations who work with pediatric cancer patients as well as those
with young adult survivor programs across the United States were contacted including, the
Coalitions Against Childhood Cancer, Alex’s Lemonade Stand, St. Baldrick’s Foundation, I Had
Cancer, Lacuna Loft and more (Appendix D). It was requested that these organizations share the
survey link on their social media post as well as contact other organizations serving the same
population.
In addition to partnering with the APOSW and nonprofits serving the target population,
an extensive search was completed to identify Facebook groups that were both open and closed.
Terms used to identify appropriate groups included “young adult survivor of childhood cancer”
“survivor of pediatric cancer” “long-term survivor of childhood cancer” “late effects of
childhood cancer” as well as disease specific groups such as “Wilms Tumor” “Osteogenic
Sarcoma” “Leukemia Survivor” “Acute Lymphoblastic Leukemia” “Acute Leukemia.” In total
32 groups were identified with a combined total of 282,665 members. Frequency in which a post
was made depended on the level of member participation. For groups with high participation
(10+ posts a week) a post was made monthly, for groups in which there was low participation
(less than 10 posts a month, and if the only post was made for this study) a post was made every
other month.
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This link remained available from August 2017 until June 2019. Once the participant
clicked on the link, they were provided with an electronic consent form informing them of their
rights as a participant and any potential risks. At the end of the online survey participants had the
opportunity to enroll in the second portion of the study. They were provided a space to enter their
phone number, email address, and select the best times and days of the week to be contacted.
This information was not linked in any way to their responses and participants were made aware
of this with a notice at the end of the questionnaire.
During Phase Two of the study, participants who self-selected to be included in the
interview portion were contacted, via e-mail up to three times to arrange a date and time to
complete the interview. After three attempts, participants who did not respond were deemed as
self-select out of the interview. Participants who responded were contacted at their preferred date
and time. Participants confirmed their identity and a brief overview of the interview process and
recording was provided. Participants were then informed they were being recorded. A script was
read, [Appendix E] with information on the purposes of the study, estimated length, and request
for verbal consent to continue. Only participants who gave verbal consent were interviewed with
the open-ended questions.
Phase One: Quantitative Data Collection
In phase one of the study, young adult survivors of childhood cancer were recruited
through online social media venues to complete an online adapted version of Champion’s Health
Belief Model Scale, about their participation in late effects screening. Quantitative data was
collected via Qualtrics®, an online data collection tool. The online survey remained open from
August 2017 until June 2019. Once the survey was closed, responses were downloaded to a
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MacBook Pro as a “csv” file; the data was cleaned and imported into IBM SPSS (Statistical
Package for the Social Sciences). The data was stored in a password-protected electronic folder.
Instrumentation
An adapted version of Champion’s Health Belief Model Constructs Instrument (1999)
[Appendix C] was used to assess if the HBM can explain young adult survivors of childhood
cancers screening for late effects. The instrument is comprised of six subscales. Each subscale
uses a five-point Likert Scale that measures the modifiable/health belief variables. Perceived
susceptibility is comprised of three items, perceived severity seven items; perceived benefits,
five items; perceived barriers, ten items; cues to action seven items; and self-efficacy, ten items,
as they relate to the a young adult survivor of childhood cancer’s participation in late effects
screening behaviors. Strongly disagree is scored using a one and strongly agree is scored using a
five.
Validity and Reliability of the Instrument
The original measurement tool was developed by Champion to measure the perceptions
and beliefs of women regarding breast cancer screening (Champion, 1999). The Health Belief
Construct Scale was tested and re-tested to assess validity and reliability. The original scales for
perceived severity, perceived susceptibility, and perceived barriers were originally found to be
internally reliable and consistent. Adjustments to the measures of perceived barriers and cues to
action were made and re-tested. The finalized tool was tested and found to be valid and reliable
(Champion, 1999).
Since the development of the tool, it has been translated and tested for validity and
reliability in numerous languages including, but not limited to Arabic, Greek, Korean,
Lithuanian, Malay, Spanish, and Turkish (α =0.61-0.94), (Abolfotouh, BaniMustafa, Mahfouz,
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Al-Assiri, Al-Juhani, & Alaskar, 2015; Anagnostopoulos, Dimitrakaki, Niakas, & Tountas, 2013;
Lee, Kim, & Song, 2002; Zelviene, & Bogusevicius, 2007; Parsa, et. al., 2008; MedinaShepherd, & Kleier, 2010; Yilmaz, & Sayin, 2014). The tool has also been adapted and tested
and found reliable and valid for Pap smear and cervical cancer screening (α= 0.62-0.86),
colorectal cancer screening (α= 0.95), and prostate cancer screening (Guvenc, et. al., 2011;
Leung, et. al., 2014; Oliver, et. al., 2011). Literature has supported the construct validity of the
instrument.
At the end of the online survey young adult childhood cancer survivors had the
opportunity to opt-into the second phase of the study by providing their phone number and email address so that a brief interview comprised of open-ended questions could be conducted.
Scoring of the Instrument
Each construct is individually measured using a summation of the scores from the items
measuring that construct (Champion, 1999; Champion, Skinner, & Menon, 2005). Perception of
behavior is a survivor’s belief about the importance of screening for late effects. This variable is
measured by subtracting the final score of the eight-item scale that measures survivors’
perceived barriers to screening for late effects from the final score of the five-item scale that
measures survivors’ perceived benefits of screening for late effects. Perceived Threat is a
survivor’s perception that late effects pose a threat to their health. Perceived Threat is measured
by combining the summative results of the 12-item sub-scale that measures survivors’ perceived
severity of late effects with the summative results of the five –item sub-scales that measures
survivors’ perceived susceptibility of late effects. Cues to Action are the concerns survivors have
to live a healthy lifestyle. Cues to Action are measured using an eight-item sub-scale that
assesses a survivor’s desire to live a healthy lifestyle. Self-efficacy, a survivor’s belief that they
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have the ability to schedule appointments specifically for late effects screening, is measured
using a 12-item scale that measures survivors’ beliefs in their ability to recognize potential late
effects and who they should call to schedule an appointment, for late effects screening. The
subscales are summed individually, and the higher the score the higher the survivors perception
or feeling about the construct (Guvenc, Akyuz, & Açikel, 2011; Louis, 2016).
Quantitative Data Analysis
Data was downloaded as a “csv” file and imported into Excel. SPSS was used to analyze
the result from the adapted version of Champions Health Belief Model scale. A cross tabulation
was computed and results were used to describe the sample characteristics using frequencies,
percentages, measures of central tendency, and variability.
Binomial logistic regression was initially proposed to answer research questions one and
two and the corresponding sub questions. Logistic regression requires a complete data set
without any missing fields to account for this the electronic survey did not allow for any
unanswered question. Before running any of the logistic regression tests to assess research
questions one and two, a cross tabulation table was assessed to ensure that data was collected
from all combination of independent variables. If cells had less than five variables and the levels
within the variables could be reduced, they were re-categorized post-hoc (Wong, 2012).
When the initial model was run, extremely large standard errors were reported, in the tens
and hundred of thousands, which is indicative of separation occurring. The two primary causes
of separation are too many variable in the model including the number of levels within each
variable, and a small sample size. Recommendations for addressing too many variables are to
reduce the number of levels within the variables, as well as reduce the number of categorical
variables, which was done.
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Firth Regression, a penalized regression method, was implemented to adjust for the high
number of variables and small sample size. Unlike binomial logistic regression, the Firth
Regression method in SPSS does not allow for hierarchical regression (block) or stepwise entry
methods. Hierarchical entry method allows researchers to enter variables into the model based on
past research with known predictor variables being entered in to the model first. In the stepwise
method predictor variables are added one at a time to the model (Field, 2009).
Table 1. Statistical Analysis Plan
Research Questions
1. What factors are associated with young
adult survivors of childhood cancers
participation in screening for late effects?
a. What are the non-modifiable factors
associated with young adult survivors of
childhood cancer’s participation in late
effects screening?
b. What are the modifiable factors associated
with young adult survivors of childhood
cancer’s participation in late effects
screening?
2. What is the relationship of modifiable
factors to young adult survivors of childhood
cancer’s participation in late effects
screening?
3. Can the health belief model be used to
explain behavior of young adult survivors of
childhood cancer as it relates to screening for
late effects?

Measures

Statistical Test
Cross tabulation
Modified Health
(Chi-Square, Pearson's Product
Belief Model
Moment Correlation, Fischer's
Scale
Exact Test)
Cross tabulation
Modified Health
(Chi-Square, Pearson's Product
Belief Model
Moment Correlation, Fischer's
Scale
Exact Test)
Modified Health Firth Logistic Regression
Belief Model
(Penalized Binomial Logistic
Scale
Regression)
Modified Health Firth Logistic Regression
Belief Model
(Penalized Binomial Logistic
Scale
Regression)
Modified Health
Firth Logistic Regression
Belief Model
(Penalized Binomial Logistic
Scale & Phone
Regression)
Interviews

To answer research question one all the non-modifiable variables assessed in the survey were
forced entered using the firth regression method (Model One). A second firth regression (Model
Two) was implemented which included the non-modifiable variables identified through previous
research as being associated with survivor’s participation in late-effects screening practices.
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These models identified the non-modifiable variables associated with a survivor’s reported
likelihood of participating in a late effects screening appointing in the next year. The variables
identified in the first two models to be associated with a survivor’s likelihood in participating in
a late effects screening appointment in the next year were then included in the next round of
regression analyses.
To answer research questions 1b. What modifiable factors were associated with young adult
survivors of childhood cancer’s participation in late effects screening and research question 2“What is the relationship of health belief factors to young adult survivors of childhood cancer’s
participation in late effects screening?” firth regression analyses were used. The modifiable
variables of the HBM, were force entered using the firth regression method to assess which
modifiable factors were associated with the intent to screen for late effects (Model Three). In
addition, the HBM modifiable constructs we force entered using the firth regression method in
Model Four.
1. What factors are associated with young adult survivors of childhood cancers participation
in screening for late effects?
a. What are the non-modifiable factors associated with young adult survivors of
childhood cancer’s participation in late effects screening?
b. What are the modifiable factors associated with young adult survivors of
childhood cancer’s participation in late effects screening?
2. What is the relationship of modifiable factors to young adult survivors of childhood
cancer’s participation in late effects screening?
The non-modifiable factors in research question 1a. included demographic variables; age
at survey, gender, race, marital status, income, education level, employment status, insurance
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status, and residential area type. The treatment related non-modifiable variables were; age at
diagnosis, time since last treatment, time since last late effects screening appointment, and
diagnosis. The non-modifiable factors were measured at the interval, ordinal, and categorical
levels. The dependent variable, how likely a survivor was to attend a late effects screening in the
next year, was measured at the ordinal level.
The modifiable variables, constructs of the health belief model, perceived susceptibility,
perceived severity, perceived benefits, perceived barriers, cues to action, and self-efficacy were
measured at the ordinal level using a five-point Likert Scale ranging from one being extremely
disagree to five being extremely agree. The outcome variable was also measured at the ordinal
level using a five-point Likert Scale and was reduced to a binomial variable, yes or no.
Extremely Likely and Likely were re-categorized as yes, Extremely Unlikely and Unlikely were
categorized as No, and participants who selected “Neither Likely or Unlikely were recategorized based on their response to the last time they attended a late effects screening
appointment. If a participant had attended an appointment in the last two years their response
was categorized as ‘yes’, and if they responded they hadn’t attended one in over two years,
including never, they were re-categorized to ‘no.’ The Health Belief Model Constructs perceived
susceptibility, perceived severity, perceived benefits, perceived barriers, cues to action, and selfefficacy were entered in to a logistic regression analysis using a force entry method. No previous
studies provide guidance on which independent variables are more influential on survivors of
childhood cancer’s late effects screening behavior.
Phase Two: Qualitative Data Collection and Handling
For the second phase of the study, participants who provided their phone numbers were
sent an initial introductory e-mail requesting specific times and days that would work best for the
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participant. After receipt of dates and times the researcher returned each e-mail with a specific
time and requested confirmation of the agreed upon interview time and date. Phone calls were
made using an iPhone 6s and recorded with TapeACall App. The researcher called each
participant, introduced herself, and informed the participant that she would begin recording the
phone call. A review of the purpose of the study, potential benefits and risks were explained to
the participant and verbal consent was acquired. Phone interviews recorded using TapeACall
App were saved as MP3 files and immediately sent via AirDrop from the connected iPhone to
the researcher’s MacBook Pro. Recorded interviews were saved with a coded name “Interview 1
mm.dd.yyyy” and so on, saved to a password-protected file on the researcher’s MacBookPro.
Once the file was successfully transferred and saved the recorded interview was deleted from the
phone. The MP3 files were uploaded to the MAXQDA. The researcher transcribed interviews in
MAXQDA.
The questions for the telephone interview were used to provide context and meaning to
the responses survivors provided in the online survey. Data from the online quantitative survey
was kept separate from the respondents’ contact information to ensure that their responses to the
online survey remained anonymous to the researcher.
The first six questions of the interview were used to obtain demographic information. The
following five questions related to treatment information. Both the demographic and treatment
data collected during the phone interviews was collected in order to determine if the phone
interview sample was similar to the sample of childhood cancer survivors who responded to the
online survey. The five open-ended questions were developed to illicit responses that either,
supported constructs of the HBM, provide insight or clarification to responses, or identify
variables not measured by the quantitative survey. Question one, “When thinking about making
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an appointment for late effects, what comes to mind?” was intended to illicit responses related to
factors survivors’ associate with late effect screening appointments. Question two, “How do you
think late effects could or do impact your life?” was intended to illicit responses related to the
constructs of severity, susceptibility, or identify additional factors survivors associate with late
effect screening. Question Three, “Have you attended an appointment to screen for late effects
in the past year?” assessed participants’ participation in late effects screening appointments.
Question 4 “What influences your decision on whether or not to make an appointment to screen
for late effects?” was intended to understand what internal and external factors motivated a
participant to schedule a late effects screening appointment. Question 5 – “What things influence
your decision to attend an appointment to screen for late effects” was intended to elicit responses
that distinguished the difference between what motivates a survivor to schedule the appointment
and what motivates them to follow through on attending the appointment they scheduled versus
canceling or not attending at all. At the end of these questions participants were invited to share
any other thoughts or comments they had about late effects and screening for them.
The audio-recorded responses to the interview questions were uploaded into MAXQDA
qualitative data analysis software. Interviews were transcribed in MAXQDA. Demographic data
was tagged for each respondent and a data table was created and used to assess descriptive
statistics of the participants in Phase Two of the study.
Qualitative Data Analysis
A grounded theory method of data analysis was used to assess the content of the recorded
phone interviews. The final product of a study using ground theory is a comprehensive theory
derived from qualitative data. Since limited research has been conducted to assess the modifiable
variables that influence a young adult survivor of childhood cancer’s participation in late effects
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screening and these studies have reported conflicting results on whether or not the HBM can
explain survivors’ behavior, grounded theory data analysis of the open-ended interview was
selected. Results from the analysis of the qualitative data helped answer research questions one
through three. The themes that developed
Data:
Interviews

Open Coding
Constant Comparison.
Memoing.

will either further support the constructs of
the HBM, help to explain young adult

Categories:
Themes develop

Properties,
sub-categories

survivors of childhood cancer’s participation
in late effects screening or identify other
variables that influence a survivor’s intent to

Emerging core
categories

participate in screening.
Coding. Coding is a process in which
Theoretical Sampling

Data: Interviews

Selective Coding
Constant Comparison.
Memoing.

researchers identify themes found within
qualitative data sets. Through coding data
that was collected during the qualitative
interviews were categorized based on the
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all three stages of coding. As categories

Basic Social
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Figure 3. Grounded theory process adapted from Jones
& Alony (2011). Coding and Memoing

developed and gain depth constant
comparison was used among the responses
simultaneously and concurrently to analyze
the collected data (Jones and Alony, 2011).
As the data begins to compile and categories
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become more apparent, memoing is used to help develop the categories and their relationships.
Memoing eventually lead to hypotheses and the formation of the theory. There are three levels of
coding that are consecutive and sequential with the product of each stage of coding leading to the
next. Figure 3 provides a visual illustration of the three coding stages of grounded theory. During
the first round of review, open coding occurred to identify broad themes that arose.
Open coding. The transcribed interviews were reviewed and 40 initial codes arose.
Selective coding. During the second stage of coding, core categories began to form. A
core category explains most of the variation, which represents the participants’ major concern.
These identified core categories should relate in a meaningful way to the other categories
(Glaser, 1978). This stage of coding enables the researcher to clarify and code data to identify
more relevant concepts. Selective coding continued until the categories become saturated, and no
other codes emerged.
Theoretical coding. The last of the three stages of coding occurs once the categories
become saturated. Saturation occurs when no new data is found after extensive data collection
seeking new categories of evidence. Examination of the categories helps to provide the
researchers with information to develop the relationships between the identified categories as
well as the literature (Glaser, 1992; 2005; Glaser & Kaplan 1996). Theoretical coding links
themes into a meaning causal relationship.
Ethical Considerations
The primary ethical considerations for all research studies are to ensure participants are
well informed about the research they are being asked to participate in, are informed about the
risks to they face as participants in the study, understand the benefits of their participation in the
study, and to feel free to make an informed decision as to whether or not they wish to participate.
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These ethical considerations were addressed through informed consent in both the online survey
and the telephone interview. Potential stress or unease may have been experienced while
completing the online survey. As part of the consent form, contact information for members of
the research team we made available so that researchers could refer participants to resources
should they experience distress from recalling aspect of their cancer treatment. The interviewer
paid close attention to verbal cues during the interview and provided the phone and website to
the American Childhood Cancer Organization (ACCO). The ACCO is able to refer survivors to
in-person services in their area, provide services over the phone, as well as electronic services
via online chat rooms and message boards.
Maintaining confidentiality, especially when highlighting specific quotations for the final
report was also an ethical concern of this study. Extreme care was taken when selecting
quotations to ensure that even other participants could not identify the source. Emotional harm
was a potential concern, as there may have been numerous negative emotions associated with
survivors’ treatment experience. This harm was weighed against the potential benefit of the
results of the study, and was addressed through proper consent.
This study was submitted to and approved by the Old Dominion University Institutional
Review Board, as was the amendment to include an incentive.
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CHAPTER IV
RESULTS
The purposed of this study was to examine the late effects screening behaviors of young
adult survivors of childhood cancer between the ages of 18-29 years old and identify the
variables that influence their behaviors. The Health Belief Model (HBM) was the primary
framework of the quantitative survey analysis and a grounded theory approach was taken to
identify themes within a series of open-ended questions related to late effects and screening
practices. The qualitative data was analyzed using SPPS and MAXQDA was used for
transcription and coding of the open-ended questions and qualitative analysis.
Phase One: Quantitative Data Analysis
Data Handling
The survey was distributed online to a minimum of 32 different social media outlets (14
Facebook Pages, 15 Private Facebook Groups, 9 Twitter) with a combined exposure to 282, 655
individuals. However, there was no way to de-duplicate the number of potential participants by
page or group, nor was there a way to only distribute to eligible participants, by age or
nationality. To address these limitations, responses that were from participants outside the
demographic parameters were excluded.
Survey data was collected using Qualtrics provided through Old Dominion. The survey
remained open for two years. Responses were checked multiple times a week to schedule phone
interviews. After the first year, 38 eligible responses were collected. An addendum to the study
was made to incorporate a raffle incentive. After another year the remaining surveys were
collected. If a survey was attempted but not completed within 14 days, the survey was recorded
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as incomplete. The survey was closed after two years and responses were downloaded as a “csv”
file and stored in a password-protected electronic folder.
All Likert-Scale responses were coded one through five, one being extremely unlikely
and five being extremely likely.
Description of the Sample
A total of 164 individuals clicked on the anonymous link to the questionnaire.
Figure 3. diagrams the enrollment of participants for both phases of the study. Of those who
initiated the survey, 102 individuals completed the survey to the thank you page, two participants
completed all questions but exited before the thank you page and 62 individuals abandoned the
survey at various points. Of the 102 surveys completed, four were excluded because they were
over 18 at the time they were initially diagnosed with cancer, four excluded because they selfdisclosed they were not a United States resident, one was excluded because a parent completed
the survey for the survivor, and one was excluded as the participant was still actively in
treatment. The final sample of Phase One consisted of 92 participants ranging from 18 years to
29 years (M=23.9,SD=3.4).
The majority of participants were female (n=74, 80.4%), with less than one-third being
male (n=18, 19.6%). Participants were predominately White (n=78, 84.8%). Hispanic/Latino(s)
(n=9, 9.8%), African American (n=3, 3.3%), and Multiracial (n=2, 2.2%) participants comprised
the remaining 15.2% of respondents. A little more than one-third of participants (n=34, 37.4%)
earned a Bachelor degree or higher.
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61 Social Media
Groups Identified
13 Groups and
Pages did not
distribute
survey

48 Groups and
Pages
distributed
survey
164 Participants
clicked the study link

62 surveys
abandoned
(37.8%)

102 surveys
completed
(62.2%)

92 surveys
analyzed
(90.2%)

10 surveys
excluded
(9.8%)
40 participants
enrolled on phone
interview
(43.5%)
12 particpants
lost to followup

28 particpants
completed
phone itnerview
(70%)

Figure 4. Recruitment and Enrollment of Study Participants

Other demographic data explored were marital status, household income, and residential
location. A large majority of young adult survivors (n= 70, 76.1%) were single. In addition,
64.1% (n=59) of participants lived in urban and suburban residential locations.
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Table 2. Characteristics of Childhood Cancer Survivors Quantitative Participants

Characteristic
Age (Mean, SD)
Age at Diagnosis
Age at Survey
Years Since
Treatment
Insurance Age
<26

Total
(N=92)
Frequency
%

Attend Appointment
Not Attend Appointment
(n=68)
(n =24)
Frequency
%
Frequency
% p-value

8.6
23.9

5.2
3.4

7.9
23.2

5.1
3.4

9.3
25.9

5.4
2.8

.278
.001**

13.7

5.8

13.4

5.9

24.3

5.7

.513
.029*

47

81

11

20

58.8

14

19
41.
2

71.7
28.3

51
11

82.3
17.7

15
5

75
25

.522

78
14

84.8
15.2

56
11

83.6
16.4

22
3

88
12

.751

21
70

22.8
76.1

13
50

17.7
80.6

8
14

30
70

.503

1

1.1

1

1.6

0

0

Bachelor's or
higher

34

37

22

32.8

12

48

Non-graduate

58

63

45

67.2

13

22.
4

54
38

58.7
41.3

38
29

56.7
43.3

16
9

64
36

.636

$0-19,999

19

20.7

18

26.9

1

4

.083

$20,000 to
$49,999
$50,000 to
$74,999
$75,000 to
$99,999

27

29.3

18

26.9

9

36

14

15.2

10

14.9

4

16

9

9.8

4

6

5

20

$100,000 or more
Prefer not to
answer

10

10.9

7

10.4

3

12

13

14.1

10

14.9

3

12

≥ 26

58

63

34

37

66
16

Sex
Female
Male

Race
White
Non-White

Marital Status
Married
Single
Prefer not to
answer

Education Level
.18

Employment
Employed
Unemployed

Income

Insurance Source
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Table 2. Characteristics of Childhood Cancer Survivors Quantitative Participants (continued)

Characteristic
Employer
Spouse or Parent
Purchased
Medicare or
Medicaid

Total
(N=92)
Frequency
%
22
23.9
47
51.1
7
7.6

Attend Appointment
Not Attend Appointment
(n=68)
(n=24)
Frequency
%
Frequency
% p-value
12
17.9
10
40
.064
37
55.2
10
40
4
6
3
12

16

17.4

14

20.9

2

8

29
13

31.5
14.1

20
8

29.9
11.9

9
5

36
20

13

14.1

10

14.9

3

12

8

8.7

7

11.3

1

5

9
20

9.8
21.7

3
15

4.8
24.2

2
2

10
10

Diagnosis
Leukemia
Lymphoma
Bone of Soft
Tissue
Central Nervous
System
Neuroblastoma
Other

Time Since Last Late
Effects Appointment
Never Attended
Less than a year
More than a year
More than two
years
More than five
years

.381

.02*
6
51
15

7.1
60.7
17.9

3
45
10

4.8
72.6
16.1

3
5
5

15
25
25

7

8.3

3

4.8

4

20

5

6

1

15

3

1.6

Notes: SD, Standard Deviation. Comparisons used Chi-square, Fischer’s Exact appropriate to the level of
measurement. p<.05* , p <.01**

Specific non-modifiable factors related to participants’ diagnosis and treatment history
were also analyzed. The majority of diagnoses were comprised of Leukemia; the most frequent
(n=29, 31.5%) followed by bone or soft tissue cancers (n=13,14.1%) and lymphoma, (n=13,
14.1%). The ‘Other’ category was composed of seven diagnoses; Kidney tumor (n=5),
Retinoblastoma (n=3), Germ Cell (n=2), Heptoblastoma (n=2), Ovarian (n=2), Ewing’s Sarcoma
(n=1), Pleuropulmonary Blastoma (n=1), and T-cell ALL and Non-Hodgkin’s Lymphoma (n=1).
The majority of survivors did not experience a secondary cancer or relapses (n=66, 83.5%). The
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majority of patients were diagnosed under the age of 10 years old (n=47, 60.2%). The range of
years since treatment spanned 21 years from five years since treatment to 26 years since
treatment and the majority of participants (n=47, 60.3%) had attended an appointment to screen
for late effects within the last year. Compared to survivors who were not likely to attend a late
effects screening appointment in the next year, survivors who were likely to attend an
appointment were younger at the time of the survey (M=23.2, p=0.001) less than 26 (p=.029).
Time since last late effects appointment was significantly different between survivors who were
likely to attend a late effects
Description of Score of the Health Belief Model Scale
The Health Belief Model Scale has six subscales that correspond with the six constructs
of the Health Belief Model. Table 2. details the subscales, the minimum and maximum total
score for each subscale, the observed range of the subscale scores and the measures of central
tendency for each subscales. With the exception of Perceived Benefits, none of the six subscales
covered the full span of the score range; all five other subscales were above the minimum score.
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Table 3. Description of Health Belief Model Scale Scores
Health Belief Model Construct

3-15
7-35
5-25
10-50
7-35
10-50

Observed
Score Range
(Min-Max)
4-15
12-35
5-25
11-50
16-50
16-35

11.93(2.78)
23.01(4.86)
18.67(3.92)
24.15(8.28)
41.13(6.70)
27.88(3.79)

10

10-50

20-50

34.95(6.25)

15

-45-15

-30-14

-5.48(9.09)

Number of
items

Score Range
(Min-Max)

3
7
5
10
7
10

Perceived Susceptibility
Perceived Severity
Perceived Benefits
Perceived Barriers
Self Efficacy
Cues To Action
Perceived Threat
(Perceived Susceptibility +
Perceived Severity)
Perception of Behavior
(Perceived Benefits –
Perceived Barriers)

M (S.D.)

Notes: M, Mean; SD, Standard Deviation.

Identifying Non-modifiable and Modifiable Variables
Binomial Logistic Regression was proposed to assess research questions one and two.
However, extremely large standard errors occurred which is indicative of separation. A table of
the results of this test can be found in Appendix F. To address separation, the number of levels
within each variable was reduced. Firth Regression, a statistical method for penalizing the
regression was also used to address issues of small sample size, but requires that all variables be
entered at once. In order to address over fitting the model with too many variables, three models
were tested. Model 1. Included all of the measured non-modifiable variables. Time since last late
effects appointment was found to be a significant contributing factor to the model and was
included in Model 2.
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Table 4. Odds Ratio for Model One - All Non-Modifiable Variables

Intercept
Demographic Variables
Age
Gender
Male
Female
Race
Non-White
White
College Graduate
Not a college graduate
Bachelor’s degree of higher
Marital Status
Prefer not to answer
Married
Single
Employment
Unemployed
Employed
Income
Prefer not to answer
Under $20,000
$20,000 to$49,999
$50,000 to $74,999
$75,000 to $99,999
$100,000 or more
Insurance Source
Employer Provided
Spouse or parent
Purchased Policy
Medicare or Medicaid
Residential Locality

B (SE)
-4.58(6.28)

OR (95%CI)
97.42 (-25.20 – 7.85)

-0.17(0.20)

1.19 (-0.74 – 0.29)

-0.38(1.11)

1.46 (-3.09 – 1.92)

-1.05(1.15)

2.85 (-4.95 – 1.06)

-1.08(0.91)

2.94 (-3.38 – 0.89)

0.13(3.38)
0.45(3.07)

0.88 (-7.33 – 6.96)
0.64 (-5.67 – 6.16)

0.55(1.12)

0.57 (-1.64-3.83)

1.33(1.95)
-1.06(1.37)
-0.66(1.41)
-1.72(1.43)
-1.38(1.55)

0.03(1.06)
0.24(1.89)
0.48(1.66)

0.26
2.89
1.94
5.56
3.97

(-3.75-12.43)
(-4.36 – 2.95)
(-4.84 – 2.66)
(-5.69 – 1.36)
(-5.62-1.65)

0.97 (-2.30 – 2.09)
0.79 (-4.16 – 4.48)
0.62 (-3.21 – 5.16)

Other

Rural
Small town
Suburban
Urban
Treatment Variables
Age at Diagnosis

6.82(3.65)
5.32(3.42)
5.84(3.41)
6.78(3.41)
0.06(0.14)

0
0
0
0

(-0.28 – 22.80)
(-1.41 – 20.41)
(-0.77 – 19.51)
(3.41 – 0.14)

0.95 (-0.35 – 0.04)
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Years Since Treatment
0.09(0.13)
0.91 (-0.29 – 0.45)
Table 4. Odds Ratio for Model One - All Non-Modifiable Variables (continued)

Diagnosis
Other
Leukemia
Lymphoma
Bone or Soft Tissue
Central Nervous System
Time Since Last Late Effects Appointment
Never Attend
Less than 6 months ago
More than 6 months but less than a year
More than one year
More than two years

B (SE)

OR

(95%CI)

1.07(1.18)
-0.26(1.32)
1.72(1.56)
0.33(1.55)
0.32(1.68)

0.34
1.3
0.18
0.72
0.73

(-1.35 – 4.17)
(-3.27 – 2.77)
(-1.23 – 7.29)
(-2.97 – 3.81)
(-3.35 – 4.15)

3.30(1.570
5.64(1.87)
1.93(1.52)
2.04(1.79)

0.04
0
0.15
0.13

(0.56 – 9.54)
(2.08 – 15.93)
(-0.85 – 7.68)
(-1.20 – 8.12)

B, Coefficient; SE, Standard Error; OR, Odds Ratio; CI, Confidence Interval. p<.05*, p<.001**

In model one, time since last late effects appointment was a significant predictor of a
childhood cancer survivors’ likelihood to participate in a late effects screening appointment in
the next year. Specifically, never attending a late effects appointment significantly predicted a
survivors likelihood in participating in a late effect screening appointment in the next year b=
3.192, x2(31)=5.18 p=.019, as did attending a late effects appointment in the last six months
b=5.356, x2(31) = 211.876, p <.001.Model two included the non- modifiable variables found by
previous studies to be associated with attendance at late effects along with variables identified in
the crosstab.
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Table 5. Odds Ratio for Model Two - Research Supported Non-modifiable Variables

Intercept
Demographic Variables
Age
Gender
Male
Female
Race
Non-White
White
Income
Prefer not to answer
Under $20,000
$20,000 to$49,999
$50,000 to $74,999
$75,000 to $99,999
$100,000 or more
Treatment Variables
Diagnosis
Other
Leukemia
Lymphoma
Bone or Soft Tissue
Central Nervous System
Neuroblastoma
Time Since Last Late Effects Appointment
Never Attend
Less than 6 months ago
More than 6 months but less than a year
More than one year
More than two years
More than five years

B (SE)
OR (95%CI)
4(3.75) 0.02(-3.14-12.60)
-0.14(0.12) 1.15(-0.44-0.90)

-0.84(1.12) 2.32(-3.31-1.30)

-0.46(1.12) 0.63(-2.97-1.61)

2.37(1.87)
-1.11(1.21)
-0.47(1.24)
-2.25(1.32)
-2.76(1.45)

0.09(-.98-8.42)
3.03(-3.82-1.26)
1.60(-2.97-1.61)
9.49(-5.07-0.17)
15.80(-6.06- -0.73)*

0.66(1.08)
-1.12(1.11)
1.02(1.20)
0.08(1.51)
-0.60(1.62)

0.52(-1.47-2.79)
3.06(-3.43-0.98)
0.36(-1.17-3.52)
0.92(-2.72-3.14)
1.82(-4.29-2.62)

2.96(1.37)
6.30(2.01)
1.62(1.34)
1.20(1.53)
-1.51(1.79)

0.05(0.57-6.00)*
0.00(2.80-12.10)**
0.20(-0.81-4.31)
0.30(-1.59-4.29)
4.54(-7.80-1.52)

B, Coefficient; SE, Standard Error; OR, Odds Ratio; CI, Confidence Interval. p<.05*, p<.001**

In model two, time since last late effects appointment was a significant predictor of a
childhood cancer survivors’ likelihood to participate in a late effects screening appointment in
the next year. Specifically, never attending a late effects appointment significantly predicted a
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survivors likelihood in participating in a late effect screening appointment in the next year b=
2.96, x2(18)=6.04 p=.014, as did attending a late effects appointment in the last six months
b=6.30, x2(18) = 16.09, p <.000. Income, $100,000 or more, was also a significant predictor of a
survivor’s likelihood to participate in a late effects screening appointment in the next year b=2.76, x2 (18)=4.06, p=.04.
Model 3 included the non-modifiable variables found to be significant in Model 2 as well
as all six constructs of the Health Belief Model. Self-Efficacy was the only variable associated
with a survivor’s likelihood of participating in a late effects screening appointment in the net
year b=.18, x2 (16) = 4.06, p=.044. The Odds Ratio tells us that as a survivor’s self-efficacy
increases by one unit the change in the odds of going to a late effects appointment in the next
year is 1.2, a participant is more likely to going to a late effects screening appointment if they
have a higher self-efficacy.
Table 6. Odds Ratio for Model Three - Non-modifiable Variables with HBM Constructs

Intercept
Non-Modifiable Demographic Variables
Income
Prefer not to answer
Under $20,000
$20,000 to$49,999
$50,000 to $74,999
$75,000 to $99,999
$100,000 or more
Time Since Last Late Effects Appointment
Never Attend
Less than 6 months ago
More than 6 months but less than a year
More than one year

B (SE)
OR (95%CI)
(-32.46- 13.16(5.77) 520736.79 2.18)*

0.207(1.39)
-0.39(1.18)
0.21(1.39)
-2.26(1.36)
-0.86(1.56)

0.13 (-1.38-13.47)

1.56(1.62)
3.61(2.06)
0.47(1.74)

0.21 (-1.71-10.66)
0.03 (-0.34-13.61)*
0.62 (-3.26-9.71)

0.81 (-2.77-3.35)
9.61 (-5.37-0.19)
2.35 (-4.18-2.36)
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Table 6. Odds Ratio for Model Three - Non-modifiable Variables with HBM Constructs
(continued)
B (SE)
More than two years
0.25(1.60)
More than five years
-3.42(2.20)
Health Belief Models Modifiable Variables
Perceived Susceptibility
0.03(0.15)
Perceived Severity
0.23(0.14)
Perceived Benefits
0.04(.14)
Perceived Barriers
0.03(0.08)
Self Efficacy
0.18(0.09)
Cues to Action
-0.04(0.10)

OR (95%CI)
0.78 (-3.25-10.85)
30.48 (-11.24-0.66)
0.97
0.79
0.96
0.97
0.83
1.03

(-0.43-0.38)
(-0.07-0.83)
(-0.25-0.43)
(-0.16-0.20)
(0.00-0.48)*
(-0.25-0.19)

B, Coefficient; SE, Standard Error; OR, Odds Ratio; CI, Confidence Interval. p<.05*.

An additional model, Model Four, was also assessed. It included the significant nonmodifiable variables from Model Two, and the four constructs of Champion’s Health Belief
Model (Perceived Threat, Perception of Behavior, Cues to Action and Self-Efficacy). Three
variables were associated with a survivors likelihood of attending a late effects appointment in
the next year, attending a late effect appointment in the last six-months b=4.12, x2(14) = 4.80,
p=.028; Perceived Threat, b=.14, x2 (14) = 4.08, p=.043; and Self-Efficacy b =.162, x2 (14)
=.024, p =.029.
Table 7. Odds Ratio for Model Four - Research Supported Non-modifiable Variables
B (SE)
Intercept
Non-Modifiable Demographic Variables
Income
Prefer not to answer
Under $20,000
$20,000 to$49,999
$50,000 to $74,999
$75,000 to $99,999
$100,000 or more

11.19(4.78)

2.66(1.81)
-0.58(1.15)
0.12(1.38)
-2.18(1.35)
-0.98(1.54)

OR (95%CI)
(-25.31- 72258.12 2.62)

0.07
1.78
0.89
8.83
2.67

(-0.84-11.55)
(-3.25-1.55)
(-2.79-2.97)
(-5.12-0.24)
(-4.20-2.22)
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Time Since Last Late Effects Appointment
Table 7. Odds Ratio for Model Four - Research Supported Non-modifiable Variables
(continued)
B (SE)
Never Attend
Less than 6 months ago
More than 6 months but less than a year
More than one year
More than two years
More than five years
Health Belief Models Constructs
Perception of Behavior
Perceived Threat
Self Efficacy
Cues to Action

OR (95%CI)

2.04(1.54)
4.12(2.01)
0.9(1.60)
0.65(1.58)
-2.89(2.07)

0.13
0.02
0.41
0.52
18.01

(-0.95-10.00)
(0.38-13.52)*
(-2.40-8.37)
(-2.53-8.39)
(-8.75-0.83)

0.14(0.07)
-0.02(0.06)
0.16(0.08)
-0.02(0.10)

0.87
1.02
0.85
1.02

(0.00-0.33)
(-0.18-0.11)*
(0.02-0.36)*
(-0.24-0.22)

B, Coefficient; SE, Standard Error; OR, Odds Ratio; CI, Confidence Interval. p<.05*.

Phase Two: Qualitative Data Analysis
After completing the online interview participants could self select to participate in a
follow-up phone interview. Of the 92 eligible participants 40 provided contact information. All
of the 40 potential participants were e-mailed up to three times to schedule an interview. If a
participant did not respond to the three e-mails to schedule an interview, or if the participant
scheduled an interview and after three phone call attempts with a follow-up e-mail and there was
no response the participant was considered to self select out of the phone interview. A total of
28 (70%) phone interviews were completed. Both the demographic and treatment related nonmodifiable factors were analyzed using descriptive statistics. A grounded theory approach was
used to code and identify themes within the five questions pertaining to late effects screening
behaviors.
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Description of the Phone Interview Sample
A total of 28 phone interviews were completed and a majority of the participants were
female (n=16, 76.2%), Caucasian (n=16, 76.2%), had a bachelor’s degree or higher (n= 18,
64.3%) or were employed full time (n= 18, 64.3%). Descriptive statistics of non-modifiable
variables related to diagnosis and treatment were analyzed for phone interview participants as
well. Leukemia (n=6, 28.6%), Lymphoma (n=4, 19.0%), and Ewing’s Sarcoma (n=4, 19.0%)
comprise the majority of cancer diagnoses (n=14, 66.7%) of the participants in the phone
interview. Similar to the quantitative sample, a majority of phone interview participants were not
diagnosed with a secondary cancer or experience a relapse (n=18, 85.7%). There was a
significant difference in the amount of time since last late affect appointment and attendance at a
late effects appointment (p<.001).
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Table 8. Characteristics of Childhood Cancer Survivor Phone Interview Participants
Total
(N=28)
Characteristic
Frequency
Age (Mean, SD)
Age at Diagnosis
10.6
Years Since Treatment
13.2
Age at Survey
25.8
Insurance Age
<26
9
≥ 26
19
Sex
Female
23
Male
5
Race
White
25
Non-White
3
Marital Status
Married
11
Not Married
17
Education Level
Bachelor's or higher
18
Non-graduate
10
Employment Status
Employed
18
Unemployed
10
Diagnosis
Leukemia
9
Lymphoma
5
Bone of Soft Tissue
6
Central Nervous
System
2
Neuroblastoma
2
Other
4
Time Since Appointment
Never Attended
3
Less than a year
14
More than a year
5
More than two years
4
More than five years
2

%

Attend
Appointment
(n=14)
Frequency
%

Not Attend Appointment
(n =14)
Frequency

%

p-value
.419
.594
.545
.500

5.1
5.5
3.4

11.4
12.6
25.4

5.5
6.6
3.4

9.8
13.8
26.1

4.9
4.4
3.4

32.1
67.9

5
9

55.6
47.4

4
10

44.4
52.6

82.1
17.9

13
1

56.5
20

10
4

43.5
80

.163

89.3
10.7

12
2

48
66.7

13
1

52
33.3

.500

39.3
60.7

6
8

54.5
47.1

5
9

45.5
52.9
.347

64.3
35.7

10
4

55.6
40

8
6

44.4
60
.653

64.3
35.7

9
5

9
5
.691

32.1
17.9
21.4

4
4
3

44.4
80
50

5
1
3

55.6
20
50

7.1
7.1
14.3

0
1
2

0
50
50

2
1
2

100
50
50

10.7
50
17.9
14.3
0

3
13
1
0
0

100
92.9
20
0
0

0
1
4
4
2

0
7.1
80
100
100

<.001**

Note: Comparisons used Chi-square, Fischer’s Exact appropriate to the level of measurement. p<.05* , p <.01**
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Five open-ended questions were asked of each participant: 1-‘What comes to mind when
you think about late effects?’ 2 - ‘How do you think late effects impact your life?’ 3 -‘What
influences your decision on whether or not to make an appointment to screen for late effects?’; 4
-‘What things influence your decision to attend an appointment to screen for late effects?’; 5 “Do you have any additional thoughts or comments about screening for late effects. Each
participant has as much time as they would like to respond. A final opportunity was given to
each survivor to express any thoughts, feelings, opinions, or concerns about late effects,
screening, appointments or anything else related that they wanted to. If the research was able to
provide resources for the participants, a follow-up email with resources tailored to the survivor’s
expressed need was sent.
Coding was done in three rounds. In the first round the researcher read through each
interview individually and coded the responses in each interview. In round two, interview
transcriptions were then segmented by question and a second round of coding was conducted in
which themes or phrases that appeared were also coded. In round three, when codes appeared
similar, the content of the coded segment was reviewed again to see if the codes were similar
enough to be combined under a new code or needed to remain separate. The final list of codes
was reviewed and compared against questions in Champion’s Health Belief Model Scale, the
constructs of the HBM, constructs of the Social Cognitive Theory and Theory of Planned
Behavior. The final list of codes closely aligned with the constructs of the HBM as well as
potential modifying factors, which are described below.
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Perceived Susceptibility
Survivors expressed their concern about specific health issues based on their diagnosis
and treatment plan. Their concern for these issues exemplifies their perceived susceptibility of
developing a late effect (Table 8.).
Table 9. Category Perceived Susceptibility and Explanation

Likely to get a
late effect

Oh, what would make me do it right away would
be the level of discomfort I am in or my level of
concern for what is going on if its something new
that I have never had to deal with before it usually
something I try to get in to see my regular doctors
right away about.”
“a current symptom that I’m having that I really
want to address that’s definitely one.”

Perceived
Susceptibility

Chance of
getting a late
effect is great

Interviewee 6: “Right now I’m dealing with late
effects of some jaws and sinus issues of late effects
and I have had to have for the past three years
multiple very intensive surgeries um to deal with
the impacts my cancer had on me, even though it’s
not the tumor that I am having to treat. Um But its
definitely I’ve been learning to share that late
effects are going to be following me for the rest of
my life, uh weather I want to or not and with each
new season of life I’m going to have more late
effects pop up probably.”
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Perceived Severity
The perceived severity of late effects is a survivor’s assessment of the impact a late effect
may have on their current and future health. Table 9. outlines the most common concerns
regarding the severity of future late effects. Heart issues are of the utmost concern to survivors of
this study.
Table 10. Category Perceived Severity and Explanation

Interviewee 7:“ There’s been a lot of some big impact and small
impact some of it’s been for a long time there was a lot of fear,
um cause I just didn’t know what to expect....
Late
effects
scare me

“...It’s probably not the best decision but there’s definitely an
aversion to the word oncologist as fabulous as mine was, finding
a new doctor is scary and then having those yearly appointments
is scary and kind of puts that knot in your stomach which
probably isn’t the best response but there it is.”

Perceived
Severity
Interviewee 10: “Um I think specifically for my chemo and
cancer diagnosis a lot of heart things come to mind ‘cause that’s
what’s been told to me, or secondary cancers from chemo.”
Specific
concern

Interviewee11: “we talk about the possibility of heart failure
which is the number one I guess side effect of the chemotherapy
I took is congestive hear failure”
Interviewee 15: “Um. heart failure for me.”
Interviewee 17: “Um. heart problems.”
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Perceived Benefits
A survivor’s perception of the benefits to screening for late effects includes their beliefs
on the effectiveness late effects screening appointment have on reducing the threat and or
impact having a late effect will have on their health and life. Participants expressed that it was
better to know what was going on so that they could begin addressing the health issue,
suggesting that they perceived a benefit to participating in screening for late effects.
Table 11. Category Perceived Benefits and Explanation
Attending a late
effects reduces
worry

Perceived
Benefits

Find a late
effects earlier

Interviewee 4: “I know that I need to go even if I don’t want to
go, because I need to make sure that nothing else is wrong with
me and it’s kind of just for my own peace of mind. Because if I
don’t go I don’t know what is happening inside my body.”
Interviewee 1: “my longevity of my life, um my quality of life,
and my family, spending time with them motivates me. um….
and… just fear of something popping up and um not catching it
as early as I can.”
Interviewee 6: “Um and I think that especially for me as a
young adult now um it was a hard reality that I had to face, that
late effects came with the package that I wasn’t aware of at the
beginning um and so it does suck, but I think its important uh
because you know I think as a survivor I’ve already survived
cancer and I don’t want to let a late effect to be the thing to ail
me more um so its important to stay on top of late effects and
um just like with cancer they don’t define your life but they’re
important to take care of.”
Interviewee 7: “Um just ‘cause I’d rather get out in front of it,
at the end of the day than not be aware if there’s an issues.”

Late Effects
appointment
best way to find
a late effects

Interviewee 1: “um but the fear of the late effects occurring
overpowers the barriers.”
Interviewee 5: ”Um answers and hopefully a solution to the
pain and discomfort that I feel from the late effects.”
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Perceived Barriers
For young adult survivors, barriers are not just limited to their perceptions of barriers but
also encompass physical, logistic, and financial barriers to participating in late effects screening
appointments.
Table 12. Category Perceived Barriers and Explanation
Cost

Interviewee 9: “And sometimes doing that’s hard because it’s so
expensive but you just can’t live any other way.”

Continuity of
Care

Interviewee 21: “...and so since I’ve been moving around since college
and moved all over the country I haven’t had that continuity with a
doctor...”

Negative
Experience
with Health
Care
Professionals

Fear/Anxiety
Perceived
Barriers

Interviewee 21: “Um I guess like my it’s a couple factors and so like I
haven’t been very comfortable with my pediatric oncologist... and I don’t
have a lot of trust for doctors and it take a lot of time for me to build
trust.... but I would say it is more along the lines of distrust for health care
professionals in general.”
Interviewee 22: “I’m often met with responses like you don’t have cancer
you’re fine. Like we’ll check to see if you have skin cancer but you don’t
so calm the fxxx down you’re over reacting.”
Interviewee 7:“It’s probably not the best decision but there’s definitely an
aversion to the word oncologist as fabulous as mine was, finding a new
doctor is scary and then having those yearly appointments is scary and
kind of puts that knot in your stomach which probably isn’t the best
response but there it is.”
Interviewee 1: “And then sometimes some barriers for making them can
be um just time constraints, um being too busy, sometimes its also just
because I get nervous...”

Time
consuming
Inconvenient
More
important
things to do

Interviewee 3: “So having to go to all the appointments there are times
when if they tell me to go to a breathing appointment I know there’s no
changes so I don’t go. So it’s more or less we’re all willing to go get our
blood work and do our yearly screenings that are like the important ones
but some of the ones that are a little less important ones sometimes don’t
happen because of time off of work, finances, you know all the things that
can impact you from having access to some of that even just you know
where your appointment is located makes it difficult sometimes.”
Interviewee7: “Um to screen and to check in and it was really distributive
to be away at college I mean it’s an awful thing to complain about like
you’re cancer free and you’re complaining about going to monthly doctors
appointments but when you’re 18 and you have better things to do
*nervous giggle* you know um but um I guess now it’s more just a matter
of like having to know what I should be aware of with my health.”
Interviewee 15: “Convenience, whether or not I have time”
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Cues to Action
Cues to action are triggers for survivors to attend a late effects appointment. The Health
Belief Model Scale focused on general health domains, such a healthy lifestyle and diet, but
participants of the phone interview identify more concrete external cues, including family
involvement and concerns about an immediate health issue (Table 12.).
Table 13. Cues to Action and Explanation

Cues to
Action

Good health
is important
to me

Interviewee 1: “uh, what motivates me to make the appointment is
uh just in order to keep my health at the most optimum level”
Interviewee 5: ‘mainly just trying to keep myself healthy um and
to also help others who may be going through the same situation.”
Interviewee 6 “Um, well I do follow the rule of going every year,
um typically.”

I eat well
balanced
meals

Interviewee 14: “Um I definitely, have be a lot more careful with
things um or I should be more careful with things like diet and
what I do in my day-to-day life.”

Regular
Health
Appointment

Interviewee 4: “I see my primary care doctor every year for
routine check ups so I know that if I have any concerns about
potential late effects I can talk to her and that she would then be in
contact with my oncologist. Um but I think that just because of the
reassurance from my oncologist that um while its important you
know to be getting routine health care um she doesn’t expect
really any new late effects to pop up now.”
Interviewee 20: “Um well I have always maintained the mindset
that I need to go to my yearly oncology check up appointment”

Appointment
already made

Interviewee 7: “Um, if, so if I go out of my way to make the
appointment, I’ve kind of committed myself to go and so I will go
to appointments I’ve made. The threshold for me is really making
the appointment.”
Interviewee 10: “Um my mother makes me *giggles*”

External
Influence

Interviewee 14: “My parents they’re always pushing me to set up
my appointment cause I don’t like going to late effects
appointments cause there’s always something new.”
Interviewee 19: “Uh they [Oncology office] actually, they keep
up, they call me each just to remind me that I need to get my
appointments in.”
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Self-Efficacy
In the context of the study, a survivor’s self-efficacy is their confidence in their ability to
make an appointment to screen for late effects. This included domains from feeling comfortable
talking with providers to knowing where and how to screen for late effects.
Table 14. Self-Efficacy Theme and Explanation
Interviewee 2: “on I don’t actually know of a
clinic near me that does late effect screening
specifically...So that’s why I haven’t ever done
one, because I don’t know where to go or who
to talk to.”
Know how to
find a place to
screen for late
effects
Self-Efficacy
Capable of
making late
effects
appointment
Comfortable
talking to
people about
late effects
concerns

Interviewee 6: “Um I, having just moved I’m
actually going to be looking this summer for a
um primary care physicians who specializes in
oncology so that I can find somewhere to go to
late effects appointments here. Um my new
town but um I think once a year and then um
especially in years where there’s big changes.”
Interviewee 20: “I also call and make an
appointment to get checked out”
Interviewee 8: “I feel very comfortable with and
it’s very easy for me to make an appointment
with them and work with my school schedule.”

The factors that influence phone interview participants to attend a screening appointment
are closely related to the constructs of the HBM and it is apparent that once an appointment is
made to attend a late effects screening appointment survivors have stated they will attend the
appointment. Knowing this can play a role in how health care providers design messaging
around scheduling and attending late effects screening appointments.
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Chapter Summary
This study recruited 92 eligible participants to complete phase one of this study, an
adapted version of the Health Belief Model Scale. Demographic data demonstrated that the
sample was pulled from a wide range of ages and diagnoses. However, the majority of
participants in both the online survey and the phone interview were white females, and an
overwhelming majority of phone interview participants had at least a four-year college degree.
While the quantitative portion in Phase One did not result in a model that included modifiable
and non-modifiable variables, the qualitative results from Phase Two provided insight into young
adult survivors of childhood cancer’s thoughts and beliefs around late effects and screening for
them.
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CHAPTER V
DISCUSSION AND CONCLUSION
In this two-phased mixed methods study, a modified version of Champion’s Health
Belief Model Scale was used to assess the health beliefs of young adult survivors of childhood
cancer and a series of open-ended question phone interviews were completed to further
understand the health beliefs and needs of young adult survivors of childhood cancer.
Measurement Tool
Champion’s Health Belief Model has been utilized among numerous populations and
translated in multiple languages and found valid and reliable. While testing and validating the
modified version of Champion’s Health Belief Model Scale was not a focus of this study, the
scores of each subscale and measures of central tendency were computed and compared to those
of previous studies. Two studies reported the range of scores and measures of central tendency
(mean and standard deviation) Pirzadeh (2018) and Umeh (2001). The mean and standard
deviations of this study were similar to those of Pirzadeh (2018). The Pirazadeh (2018) study
was conducted among Iranian women age 18-44 and assessed participation in breast self-exams
and the Umeh (2001) study assed self –breast exam behaviors of British women18-35 year old.
The scores of the subscales in this study are most similar to those of the Pirzadeh (2018) study.
While this does not prove the validity of the adapted scale for young adult survivors of childhood
cancer, it suggests that the scale is similar to those that are valid and reliable in other
populations.

74

Table 15. Comparison of Study Scores to other Health Belief Model Scale Scores

Mantlo
(n=92)

Umeh
(n=269)

Pirzadeh
(n=384)

Health Belief Model
Construct

Number of
items

Perceived Susceptibility

3

11.93(2.78)

12.73(3.10)

8.37(2.43)

Perceived Severity
Perceived Benefits
Perceived Barriers
Self Efficacy

7
5
10
7

23.01(4.86)
18.67(3.92)
24.15(8.28)
41.13(6.70)

34.74(7.45)
13.12(1.6)
15.14(5.16)
--

23.83(4.65)
20.56(3.86)
23.37(4.87)
--

Cues To Action

10

27.88(3.79)

--

24.73(8.78)

M (S.D.)

Notes: M, Mean; SD, Standard Deviation.

Interpretation of Research Questions One and Two
Three variables, Age at Time of the Survey, Insurance Age, and Time Since Last Late
Effect appointment were identified as non-modifiable variables related to a young adult survivor
of childhood cancer’s intent to participate in a late effect screening appointment in the next year.
Age of the survivor has been found to be associated with a survivor’s likelihood to participate in
late effects by previous researchers, with younger survivors more likely to attend a late effect
(Oeffinger et. al., 2004; Arvidson, et. al., 2006; Michel, et. al., 2010). In the United States,
young adults are allowed to stay on their parents’ health insurance until the age of 25; at 26 they
must obtain their own insurance. Insurance Age (whether a survivor was less than 26, or 26 and
older) was associated with a survivor’s participation in late effects screening. This may suggest
that this age break is an important factor, whether it is because parents are influential to younger
survivors screening practices, survivors are able to still see their pediatric provider until the age,
or another reason cannot be concluded from this study, but provides guidance for future research.

75
In addition, four different models were tested to identify the non-modifiable variables and
modifiable variables that may be associated with young adult survivors of childhood cancer’s
participation in late effects screening. Model 1 assessed all of the non-modifiable variables from
the online survey and only Time Since Last Late Effects was found to be a significant predictor
of a survivor’s intent to attend a late effects appointment, specifically if a survivor had attended
an appointment in the last 6 months (p=. 019) or last year (p<.001). Levels within this variable
were also significantly associated with attendance (less than six months, p= .014 and More than
6 months and less than a year, (p<.001) in Model 2 which tested both variables from previous
studies, and those identified in the crosstab of this study. During the Qualitative portion of the
study participants mentioned that when they attended a late effects appointment they would
either schedule their next appointment, or their physicians would follow-up with phone calls to
schedule an appointment. Survivors also mentioned in the qualitative portion of the study that
they felt like a late effects screening appointment was like a yearly check-up or something that
they should do regularly. This might suggest an area for further research into reframing late
effects appointments as part of a survivor’s annual physical or further understanding into
survivors’ general perceptions and beliefs of health behaviors.
The two variables that were significant in Model Two were household incomes of
$100,000 or more (p =.044) and Time Since Last Late Effect Appointment (less than six month
p=.014, more than six months but less than a year, p<.001). However, when these nonmodifiable variables were included with the modifiable variables from the Health Belief Model
Scale in Model 3, only the HBM construct of Self-Efficacy was associated with a survivor’s
intent to attend a late effects screening appointment (p=.04). Model 4 assessed the constructs of
Champions’ Health Belief Model Scale. Self-efficacy was a significant contributor to Model 3,
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other studies have also found self-efficacy to be contributing factor to cancer survivors,
screening practices (Kadan-Lottick et. al, 2002; Byrne, Lewis, Halamek, Connelly, & Mulvihill,
1989; Leung, Wong, & Chan, 2014). Young adult survivors of childhood cancer are going
through many transitions in their life from moves to job and insurance changes.
Interpretation of Research Question Three
While the full theoretical framework of the HBM was found to not be a good fit in Phase
One, the coded responses from individual interviews in Phase Two provided by young adult
survivors of childhood cancer corresponded to the constructs of the HBM. In Phase One, each
construct of the HBM was assessed by a subscale within the survey. While all six of the
constructs were present in survivor’s responses, not all of the themes within each subscale were
discussed (e.g. Perceived Susceptibility was comprised of three themed questions 1- likely to get
a late effect, 2- chance of getting a late effect are great, 3- develop a late effect in the future).
Additionally, themes specific to young adult cancer survivors’ experiences arose, which
corresponded with the constructs of the model. A revision to the modified Health Belief Model
Scale that reflects the beliefs of this specific population could more accurately assess young adult
survivors of childhood cancer health beliefs as they related to late effects screening.
Of note, was the number of survivors who expressed that they did not know about late
effects and their severity, prevalence, or that they should be screening specifically for them. This
is consistent with other studies that have found pediatric cancer survivors are not able to recall
treatment or the medications they received (Byrne, Lewis, Halamek, Connelly, & Mulvihill,
1989; Kadan-Lottick et. al, 2002). This lack of knowledge could be a potential moderating
variable that was not measured or assessed in Phase One of the study either as a non-modifiable
variable or within the modified version of Champion’s Health Belief Model Scale. Figure 5.
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diagrams the HBM and the representative explanatory quotes from the structured phone
interviews during Phase Two of the study.
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Figure 5. Theoretical Model with Explanatory Quotes
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Limitations and Strengths of the Study
As with all research, this study had its limitation. Recruitment of a large enough sample
size was a significant limitation. Research has supported using social media as an effective
approach for recruiting survey participants. However, this did not prove to be the case for this
study even after adding an incentive for participants. In addition, selection bias may have
occurred since participants self-selected to participate. Survivors who are more invested in their
treatment protocol or have concerns about potential late effects may be actively seeking
information and may have been more willing to participate in a survey related to late effects. The
strength of this technique is that it provided a sample of participants from across the United
States from different geographic locations that limited the influence of a particular clinic’s
approach to late effects screening.
The nonrandom sampling method has the potential for internal and external threats to
validity. The results may not be generalizable to the large population of survivors if those who
self-select to participate are not representative of the larger population. While not a nationally
representative sample of young adult survivors of childhood cancer the sampling method did
allow for the inclusion of participants from across the United States. Additionally, the recoding
of the outcome variable from six to five levels, specifically reducing the “Less than 6”six months
ago “and “More than 6 months but less than a year ago” categories to “Less than a year ago”
may have influenced statistical association of time since last late effect appointment and the
outcome of young adult survivor of childhood cancer’s intent to participate in a late effect
screening appointment in the next year.
Unintended bias is another limitation of studies conducted using grounded theory. While
researchers should be as unbiased as possible when interpreting the results, it is almost
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impossible to completely separate the researchers’ knowledge or perception of data especially
when attempting to interpret an arising theory. Starting with the HBM as a theoretical framework
for the Phase One of the study could have influenced coding. A strength of the study, intended to
address this limitation was the incorporation of an outside reviewer, who works with pediatric
cancer survivors. The outside reviewer read through a selected number of interviews and
developed codes independently of the researcher. Codes for the selected interviews were
compared for reliability.

Implications
Policy implications. There are a number of policy implications that arose from this
study. At the national level, legislative changes should be made to the Patient Protection and
Affordable Care Act to require insurance companies to cover the cost of screening for late
effects. During Phase Two of the study, survivors reported that the lack of coverage by their
insurance for tests needed to screen for late effects was one of the barriers to their participation
in late effects screening. The Patient Protection and Affordable Care Act (2010) required
insurance companies to cover the cost of certain screening and preventative measures to include
screening for sexually transmitted infection, colorectal cancer for those over 50, cholesterol,
Type II Diabetes, blood pressure, and more. It’s projected that there will be over 500,000
pediatric cancer survivors by 2020 (Robison and Hudson, 2014). Incorporating late effects
screening tests to be considered part of the required preventative care covered by insurance
companies may not only reduce or eliminate this as a barrier for survivors but it may also reduce
the financial strain on survivors. This policy change may also enable the detection and treatment
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of late effects at an earlier stage with a potentially lower cost to both the survivor and insurance
companies.
At a more regional and local level, institutional policies could be established between
healthcare facilities that would not only provide education about late effects to survivors but also
establish a network of primary care physicians’ knowledgeable about late effects that survivors
could transition to directly after aging out of pediatric care. In addition, changes to physician
training could be instrumental for survivors. Currently, continuing education units are available
to providers if they’re at a conference that offers the course or choose to participate (Meacham,
Lillian, Edwards, Cherven, Palgon, et al., 2017). This only reaches a limited audience of
physicians. However, if a section of one medical course was required as part of all medical
training on the need for late effects screening for physicians, nurses, and physicians assistants,
then medical providers would at least be aware of these needs.
In addition, the development of a universal transition program that addresses the
informational needs of survivors along with targeting their health beliefs could help to ensure
survivors are adhering to screen guidelines and detecting late effects earlier. Pediatric cancer
survivors who develop breast cancer are at a higher risk of mortality compared to the general
population (Moskowitz, Chou, Neglia, Partridge, Howell, Diller, et. al., 2019).
With proper screening earlier detection may decrease mortality rates. Participants of this study
mentioned their need to adhere to a better diet and physical activities which coincides with the
high rate of obesity among childhood cancer survivors (Li, Beltran, Baranowski, Thompson,
Chandra, &Baranowski, 2013). Development of a program that address the informational needs
of survivors to include how to over come barriers could be beneficial in address the concerns
identified in Phase Two of the study. Promotion of healthy eating habits and behaviors, along
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with screening practices could help address some of the late effects such as obesity and higher
rates of mortality.
Implications for Future Research. While the results of quantitative assessment in Phase
One of the study did not support a model that included any of the non-modifiable or modifiable
variables in a regression model, the themes identified in the structured interviews in Phase Two
suggest that further modification of the Health Belief Model Scale may be needed for this
specific population. Further validation and modification of Champion’s Health Belief Model
Scale is needed.
In addition to modifying the measurement tool, further research could and should be
conducted among survivors outside of the targeted age group and geographic constraints. This
would provide further insight into the health beliefs of childhood cancer survivors who have
been even further out from treatment and are less aware of screening for late effects. Individuals
within the social media groups who were outside the eligibility criteria noted significant
informational needs about late effects and screening for them in response to recruitment for
participants in the study.
Conclusion
The purpose of this study was to assess young adult cancer survivors’ participation in late
effects screening appointments, by identifying the non-modifiable and modifiable factors
associated with their likelihood of attend a late effect appointment in the coming year. A mixedmethods approach with a convenience sample was used. Prior research has focused on the
demographic and treatment variables of a survivor and their relationship to late effects screening
practices of childhood cancer survivors.
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The results of this study echoed those with similar applications of Champion’s Health
Belief Model Scale among different populations. Yet the results of the firth logistic regression
models do not fully support the Health Belief Model as an explanatory model of young adult
survivors of childhood cancer’s likelihood of participating in a late effects appointment. While
the generalizability of these results is limited, they are a starting point for developing further
understanding of childhood cancer survivor’s health beliefs and practices as they relate to late
effects screening from a theory based perspective.
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APPENDIX A
CHAMPION’S HEALTH BELIEF MODEL SCALE

Perceived Susceptibility

Strongly
Agree
(5)

Agree
(4)

Neither
agree
nor
Strongly
disagree Disagree Disagree
(3)
(2)
(1)

Agree
(4)

Neither
agree
Strongly
nor
disagree Disagree Disagree
(3)
(1)
(2)

My chances of getting
breast cancer are great.
My physical health makes
it more likely that I will get
breast cancer.
I feel that my chances of
getting breast cancer in the
future are good.
There is a good possibility
that I will get breast cancer.
I worry a lot about getting
breast cancer.
Within the next year I will
get breast cancer.

Perceived Susceptibility
The thought of breast
cancer scares me.
When I think about breast
cancer I feel nauseous.
If I had breast cancer my
academics and career
would be endangered.
When I think about breast
cancer my heart beats
faster.

Strongly
Agree
(5)
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Breast cancer would
endanger my significant
relationship.
Breast cancer is a hopeless
disease.
My feelings about myself
would change if I got
breast cancer.
I am afraid to even think
about breast cancer.
My financial security
would be endangered if I
got breast cancer.
Problems I would
experience from breast
cancer would last a long
time.
If I got breast cancer, it
would be more serious than
other diseases.
If I had breast cancer, my
whole life would change.

Perceived Benefits
Doing breast self-exams
prevents future problems
for me.
I have a lot to gain by
doing breast self-exams.
Breast self-exams can help
me find lumps in my
breast.
If I do monthly breast
exams I may find a lump
before it is discovered by
regular health exams.
I would not be so anxious
about breast cancer if I did
monthly exams.

Strongly
Agree
(5)

Agree
(4)

Neither
agree
nor
Strongly
disagree Disagree Disagree
(3)
(1)
(2)
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Having breast exams
performed by a physician
prevents future problems
for me.
I have a lot to gain by
having breast exams
performed by a physician.
Breast exams performed by
a physician can help me
find lumps in my breast.
If I have a breast exam
performed by a physician
every three years, I may
find a lump before it is
discovered by self breast
exams.
I would not be so anxious
about breast cancer if I had
a breast exam performed
by a physician every three
years.
It is embarrassing for me to
have a breast exam
performed by a physician.

Perceived Barriers
It is embarrassing for me to
do monthly breast exams.
In order to do monthly
breast exams I have to give
up quite a bit.
Breast self-exams can be
painful.
Breast self-exams are time
consuming.
My family/ friends would
make fun of me if I did
breast self-exams.
The practice of breast selfexams interferes with my
activities.

Strongly
Agree
(5)

Agree
(4)

Neither
agree
nor
Strongly
disagree Disagree Disagree
(3)
(1)
(2)
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Doing breast self-exams
would require starting a
new habit, which is
difficult.
I am afraid I would not be
able to do breast selfexams.
It is embarrassing for me to
have a breast exam
performed by a physician.
In order to have a breast
exam performed by a
physician every three
years, I have to give up
quite a bit.
Breast exams performed by
a physician can be painful.
Breast exams performed by
a physician are time
consuming.
My family/ friends would
make fun of me if I have a
breast exam performed by
a physician.
The practice of breast
exams performed by a
physician interferes with
my activities.
Having breast exams
performed by a physician
would require starting a
new habit, which is
difficult.
I am afraid I would not be
able to go to a breast exam
performed by a physician.
Having breast exams
performed by a physician
are expensive.
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Cues to Action

Strongly
Agree
(5)

Agree
(4)

Neither
agree
nor
Strongly
disagree Disagree Disagree
(3)
(2)
(1)

Agree
(4)

Neither
agree
nor
Strongly
disagree Disagree Disagree
(3)
(1)
(2)

I eat a well-balanced diet.
I always follow medical
orders because I believe
they will benefit my state
of health.
I frequently do things to
improve my health.
I take vitamins when I
don't eat good meals.
I search for new
information related to my
health.
I have the recommended
yearly physical exams in
addition to visits related to
illness.
I have the recommended
periodic dental exams in
addition to visits for a
specific problem.
I exercise regularly- at least
three times a week.

Self-Efficacy
I know how to perform a
breast self-exam.
I have performed a breast
self-exam.
I have performed a breast
self-exam in the past year.
I have performed a breast
self-exam in the past 3
months.

Strongly
Agree
(5)
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I have performed a breast
self-exam in the past
month.
I feel confident that if I
perform a breast self-exam,
I could feel any
abnormalities in my breast.
I know how to get a breast
exam performed by a
physician.
I have had a breast exam
performed by a physician.
I have had a breast exam
performed by a physician
in the past year.
I have had a breast exam
performed by a physician
in the past 2 years.
I have had a breast exam
performed by a physician
in the past 3 years.
I feel confident that if I
have a breast exam
performed by a physician,
any abnormalities in my
breast will be detected.
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APPENDIX B
PERMISSION TO USE AND ADAPT HEALTH BELIEF MODEL SCALE

February 22, 2016

Ms. Kristen Trost, PhD Candidate
Health Services Research
College of Health Sciences
Old Dominion University
Norfolk, VA
Dear Ms. Trost,
Thank you for your interest in my work. You have permission to view, modify, and use the Health Belief
Model Scale for your use as long as you cite my work and send me an abstract of your completed project.
Sincerely,

Victoria Champion, Ph.D., R.N., F.A.A.N.
Distinguished Professor
Edward W. and Sarah Stam Cullipher Endowed Chair
Associate Director Cancer Prevention and Control/Population Sciences
Indiana University Simon Cancer Center

VC:dg
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APPENDIX C
ADAPTED VERSION OF CHAMPION’S HEALTH BELIEF MODEL SCALE
SAMPLE COPY, DO NOT USE WITHOUT PERMISSION
The following questions are related to your experiences with childhood cancer and late effects
screening. There are no right or wrong answers and you do not have to participate in late effects
screening to complete the survey. Please select the option that best describes your feelings about
each statement.
Strongly
Strongly
Disagree Neutral Agree
Disagree
Agree
Perceive Susceptibility
1. It is extremely likely I will get a late
effect.
2. My chances of getting a late effect in
the next few years is great
3. I feel I will get a late effect sometime
during my life.
Perceived Severity
4. The thought of late effects scares me.
5. When I think about late effects, my
heart beats fast.
6. I am afraid to think about late effects.
7. Problems I would experience with late
effects would last a long time.
8. Late effects would threaten a
relationship with my significant other,
partner, or spouse.
9. If I had a late effect my whole life
would change.
10. If I developed late effects, I would
not live longer than five years.
Perceive Benefits
11. When I attend an appointment to
screen for late effects and nothing is
found, I don't worry as much about late
effects.
12. Attending appointments for late
effect will allow me to find late effects
early.
13. If I find a late effect at a late effect
appointment, my treatment for the late
effect may not be so bad.
14. Attending a late effects appointment
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is the best way for me to find a late
effect.
15. Attending a late effect appointment
will decrease my chances of dying from a
late effect.
Perceived Barriers
16. I am afraid to attend a late effects
appointment because I might find out
something is wrong.
17. I am afraid to attend a late effects
appointment because I don’t know what
will happen.
18. I don’t know how to get an
appointment to screen for late effects.
19. Attending an appointment to screen
for late effects is too embarrassing.
20. Attending an appointment to screen
for late effects takes too much time.
21. Attending an appointment to screen
for late effects is too unpleasant.
22.Health professions doing late effects
screening are rude to survivors.
23. Attending an appointment to screen
for late effects exposes me to
unnecessary radiation.
24. I cannot remember to schedule an
appointment to screen for late effects.
25. I have other problems more
important than attending an appointment
to screen for late effects.
26. I am too old to attend an
appointment to screen for late effects.
Self Efficacy
27. I can arrange transportation to attend
an appointment to screen for late effects.
28. I can arrange other things in my life
to attend an appointment to screen for
late effects.
29. I can talk to people at my late effects
screening appointment location about
my concerns.
30. I can attend an appointment to screen
for late effects even if I am worried.
31. I can attend an appointment to screen
for late effects even if I don’t know what
to expect.
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32. I can find a way to pay for an
appointment to screen for late effects.
33. I can make an appointment for an
appointment to screen for late effects.
34. I know for sure I can get an
appointment for an appointment to
screen for late effects if I really want to.
35. I know how to go about getting an
appointment for an appointment to
screen for late effects.
36. I can find a place to have an
appointment to screen for late effects.
Cues to Action
37. I want to discover health problems
early.
38. Maintaining good health is
extremely important to me.
39. I search for new information to
improve my health.
40. I feel it is important to carry out
activities that will improve my health.
41. I eat well-balanced meals.
42. I exercise at least three times a week.
43. I have regular health checkups even
when I am not sick.
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APPENDIX D

CONSENT AND FINAL ADAPTED VERSION OF HEALTH BELIEF MODEL SCALE
Consent
PROJECT TITLE: Understanding Childhood Cancer Survivors’ Participation in Screening for
Late Effects: A Mixed Methods Approach.
INTRODUCTION The purposes of this form is to give you information that may affect your
decision whether to say YES or NO to participation in this research and to record the consent of
those who say YES. Understanding Childhood Cancer Survivors’ Participation in Screening for
Late Effects: A Mixed Methods Approach. Conducted using an online survey and self-selected
participation in follow-up phone interview.
RESEARCHERS
Dr. Richardean Benjamin, PhD, RN, MPH, Associate Dean of the College of Health Sciences,
Old Dominion University
Dr. Matthew Hoch, PhD, LAT, Lecturer of Physical Therapy and Athletic Training, University
of Kentucky
Dr. Tina Haney DNP, CNS, RN, Assistant Professor of Nursing, Old Dominion University
Dr. Hadiza Galadima, Assistant Professor of Biostatistics, School of Community and
Environmental Health
Kristen Trost Mantlo, MSS, Doctoral Candidate, Health Services Research, Old Dominion
University
DESCRIPTION OF RESEARCH STUDY
Several studies have been conducted looking into survivors of childhood cancer’s participation in
late effects follow-up appointments. None of them have explained survivors of childhood
cancers’ perception about late effects on their participation in late effects follow-up
appointments. If you decide to participate, then you will join a study involving research of
survivors of childhood cancers’ participate in late effects screening. Using an online survey you
will be asked questions about your thoughts on developing a late effect if certain things are
obstacles to participating in late effects follow-up appointments, what the benefits to
participating in late effects appointments maybe, and your level of participation in attending late
effects follow-up appointments. If you say YES, then your participation will last for the online
survey is expected to take 10-30 minutes and at the end, you will have the opportunity to
volunteer to participate in a phone interview to further discuss your thoughts about late effects
follow up appointments. This follow up interview could last between 20-60 minutes. Both the
online survey and phone interview can take place in the location of your choosing. We have a
target recruitment of 250 participants.
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EXCLUSIONARY CRITERIA
You should have completed treatment for childhood cancer at least five years ago and be
between the ages of 18 and 29. To the best of your knowledge, you should not have received
any treatment for cancer within the last five years, be younger than 18 years of age, or older than
29.
RISKS AND BENEFITS
RISKS: If you decide to participate in this study, then you may face a risk of discomfort from
recalling traumatic or distressing events associated with treatment, and discomfort due to loss of
time. The researcher tried to reduce these risks by selecting a measurement tool that is been used
with similar participants and is relatively short in length. And, as with any research, there is
some possibility that you may be subject to risks that have not yet been identified. If at anytime
you feel any distress and wish to speak with someone please call 1-888-793-9355, the social
worker associated with the hospital you were treated at, or go to the link for online support
http://www.cancersupportcommunity.org/find-support/online-support BENEFITS: The main
benefit to you for participating in this study is the opportunities to provide information about
your participation in late effects follow up appointments. Others may benefit from changes made
to educational materials and program development as a result of findings from this study.
COSTS AND PAYMENTS
The researchers are unable to give you any payment for participating in this study.
NEW INFORMATION
If the researchers find new information during this study that would reasonably change your
decision about participating, then they will give it to you.
CONFIDENTIALITY
The researchers will take reasonable steps to keep private information, such as questionnaires
and interview responses confidential. The researcher will remove identifiers from the
information, and maintain all information in a password-protected file on a password-protected
hard drive and maintain this information in a locked cabinet when not in use. The results of this
study may be used in reports, presentations, and publications; but the researcher will not identify
you and will take steps to remove any identifying information when reporting results.
WITHDRAWAL PRIVILEGE
It is OK for you to say NO. Even if you say YES now, you are free to say NO later, and walk
away or withdraw from the study ‑‑ at any time.
COMPENSATION FOR ILLNESS AND INJURY
If you say YES, then your consent in this document does not waive any of your legal
rights. However, in the event of harm arising from this study, neither Old Dominion University
nor the researchers are able to give you any money, insurance coverage, free medical care, or any
other compensation for such injury. In the event that you suffer injury as a result of participation
in any research project, you may contact Dr. Richardean Benjamin the Responsible Principle
Investigator at 757-683-4960, Dr. Tancy Vandecar-Burdin the current IRB chair at 757-683-
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3802 at Old Dominion University, or the Old Dominion University Office of Research at 757683-3460 who will be glad to review the matter with you.
VOLUNTARY ELECTRONIC CONSENT
By clicking on the “Agree” button you agree that
· You have read the above information
· You understand this form, the research study, and its risks and benefits
· You voluntarily agree to participate
· You are 18 years of age or older
You may print a copy of this consent form for your records. If you have any questions, then the
researchers should be able to answer them: Richardean Benjamin, Ph.D. at 757-6834960Matthew Hoch, Ph.D. 757-683-4351Tina Haney, DNP, CNS, RN 757-683-5428Kristen
Trost, MSS 757-576-1455 If at any time you feel pressured to participate, or if you have any
questions about your rights or this form, then you should call Dr. Tancy Vandecar-Burdin the
current IRB chair at 757-683-3802, or the Old Dominion University Office of Research, at
757‑683‑3460.

o Agree (1)
o Disagree (2)
Skip To: End of Survey If Consent = Disagree
Page Break

Q 1 Current Age:
________________________________________________________________
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Q 2 Gender:

o Male (1)
o Female (2)
o Transgender (3)
o Prefer not to answer (4)
Q 3 Race:

o African American (1)
o Asian/Pacific Islander (2)
o Hispanic/Latino (3)
o Multiracial (4)
o Native American/American Indian (5)
o White/Caucasian (6)
o Not Listed (please specify) (7)

________________________________________________

o Prefer not to answer (8)

113
Q 4 What is the highest level of education you have completed?

o Grammar school (1)
o High School or equivalent (2)
o Vocational/technical school (3)
o Some College (4)
o Bachelor's Degree (5)
o Masters Degree (6)
o Doctoral Degree (7)
o Professional Degree (JD, MD) (8)
o Other (please specify) (9) ________________________________________________
Q 5 What is your marital status?

o Single, not married or living with partner (1)
o Married (2)
o Divorced (3)
o Separated (4)
o Widowed (5)
o Prefer not to answer (6)
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Q 6 Employment status:

o Employed for wages (1)
o Self-employed (2)
o Out of work and looking for work (3)
o Out of work but not currently looking for work (4)
o Homemaker (5)
o Student (6)
o Military (7)
o Retired (8)
o Unable to work (9)
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Q 7 What is your current household income (in U.S. dollars)?

o Under $10,000 (1)
o $10,000 - $19,999 (2)
o $20,000 - $29,000 (3)
o $30,000 - $39,000 (4)
o $40,000 - $49,000 (5)
o $50,000 - $74,999 (6)
o $75,000 - $99,999 (7)
o $100,000 - $150,000 (8)
o Over $150,000 (9)
o Prefer not to answer (10)
Q8 What kind of area do you reside?

o Rural (1)
o Small town (2)
o Suburban (3)
o Urban (4)
o Other (please specify) (5) ________________________________________________
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Q 9 How is your insurance provided?

o Through your place of employment (1)
o Through your spouse's or parents' policy (2)
o Through a policy you have purchased yourself (3)
o Medicaid or other public assistance program (4)
o Medicare (5)
o Military insurance/Veteran's benefits / CHAMPUS (6)
o Other (please specify) (7) ________________________________________________
Q 10 Age at diagnosis (to the nearest year):
________________________________________________________________
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Q 11 What was your cancer diagnosis?

o Leukemia (ALL) (1)
o Leukemia (AML) (2)
o Leukemia (Biphenotypic) (3)
o Tumor of the central nervous system (brain, spinal cord, lobe, cerebellum) (4)
o Hodgkin Lymphoma (5)
o Non-Hodgkin Lymphoma (6)
o Kidney Tumor (7)
o Neuroblastoma (8)
o Soft Tissue Sarcoma (9)
o Bone Tumor (10)
o Other (please specify) (11) ________________________________________________
Q 12 At any time following your original diagnosis, were you diagnosed with another cancer,
leukemic, tumor or similar illness (include any relapse or recurrence of his/her original
diagnosis)?

o Yes (1)
o No (2)
Display This Question:
If Q 12 = Yes
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Q 12a Was this a:

o Recurrence of your original diagnosis (1)
o New cancer, leukemia, or similar illness (2)
o Do not know (3)
Q 13 To the nearest year, how long has it been since you last received treatment for cancer?
________________________________________________________________

Q14 When did you last attend an appointment to screen for late effects?

o Have never attended (1)
o Less than 6 months ago (2)
o More than 6 months but less than a year (3)
o More than one year ago (4)
o More than two years ago (5)
o More than five years ago (6)
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Q15 How likely are you to attend an appointment within the next year to specifically screen for
late effects?

o Extremely likely (1)
o Somewhat likely (2)
o Neither likely nor unlikely (3)
o Somewhat unlikely (4)
o Extremely unlikely (5)
Page Break
The following questions are related to your experience with childhood cancer and late effects
screening. Late effects are defined as problems related to cancer treatment that occurs or
continues after treatment is completed. Screening for late effects includes attending
appointments and performing self-checks specifically to detect potential problems that may be
related to cancer treatment. There are no right or wrong answers, and you do not have to
participate in late effects screening to complete the survey. Please select the option that best
describes your feelings about each statement.
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Q16 Susceptibility
Strongly
agree (1)

Agree (2)

Neutral (3)

Disagree (4)

Strongly
disagree (5)

It is extremely
likely I will
get a late
effect. (4)

o

o

o

o

o

My chances of
getting a late
effect in the
next few years
is great. (5)

o

o

o

o

o

I feel I will get
a late effect
sometime
during m life.
(6)

o

o

o

o

o
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Q 17 Severity
Strongly
agree (1)

Agree (2)

Neutral (3)

Disagree (4)

Strongly
disagree (5)

The thought
of late effects
scares me. (1)

o

o

o

o

o

When I think
about late
effects, my
heart beats
fast. (2)

o

o

o

o

o

I am afraid to
think about
late effects.
(3)

o

o

o

o

o

Problems I
would
experience
with late
effects would
last a long
time. (4)

o

o

o

o

o

Late effects
would
threaten a
relationship
with my
significant
other, partner,
or spouse. (5)

o

o

o

o

o

If I had a late
effect my
whole life
would
change. (6)

o

o

o

o

o

If I developed
late effects, I
would not
live longer
than five
years. (7)

o

o

o

o

o
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Q18 Benefits
Strongly
agree (1)

Agree (2)

Neutral (3)

Disagree (4)

Strongly
disagree (5)

When I attend
an
appointment
to screen for
late effects
and nothing is
found, I don't
worry as
much about
late effects.
(1)

o

o

o

o

o

Attending
appointments
for late
effects will
allow me to
find late
effects early.
(2)

o

o

o

o

o

If I find a late
effect at a lat
effect
appointment,
my treatment
for the late
effect may
not be so bad.
(3)

o

o

o

o

o

Attending a
late effects
appointment
is the best
way for me to
find a late
effect. (4)

o

o

o

o

o

Attending a
late effect
appointment
will decrease
my chances

o

o

o

o

o
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of dying from
a late effect.
(5)
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Q19 Barriers
Strongly
agree (1)

Agree (2)

Neutral (3)

Disagree (4)

Strongly
disagree (5)

I am afraid to
attend a late
effects
appointment
because I
might find
something is
wrong. (1)

o

o

o

o

o

I am afraid to
attend a late
effects
appointment
because I
don't know
what will
happen. (2)

o

o

o

o

o

I don't know
how to get an
appointment
to screen for
late effects.
(3)

o

o

o

o

o

Attending an
appointment
to screen for
late effects is
too
embarrassing.
(4)

o

o

o

o

o

Attending an
appointment
to screen for
late effects
takes too
much time.
(5)

o

o

o

o

o

Attending an
appointment
to screen for

o

o

o

o

o
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late effects is
too
unpleasant.
(6)
Health
professionals
doing late
effects
screening are
rude to
survivors. (7)

o

o

o

o

o

Attending an
appointment
to screen for
late effects
exposes me to
unnecessary
radiation. (8)

o

o

o

o

o

I cannot
remember to
schedule an
appointment
to screen for
late effects.
(9)

o

o

o

o

o

I have other
problems
more
important
than
attending an
appoint to
screen for late
effects. (10)

o

o

o

o

o

I am too old
to attend an
appointment
to screen for
late effects.
(11)

o

o

o

o

o
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Q20 Self-Efficacy
Strongly
agree (1)

Agree (2)

Neutral (3)

Disagree (4)

Strongly
disagree (5)

I can arrange
transportation
to attend an
appointment
to screen for
late effects.
(1)

o

o

o

o

o

I can arrange
other things
in my life to
attend an
appointment
to screen for
late effects.
(2)

o

o

o

o

o

I can talk to
people at my
late effects
screening
appointment
location
about my
concerns. (3)

o

o

o

o

o

I can attend
an
appointment
to screen for
late effects
even if I am
worried. (4)

o

o

o

o

o

I can attend
an
appointment
to screen for
late effects
even if I don't
know what to
expect. (5)

o

o

o

o

o
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I can find a
way to pay
for an
appointment
to screen for
late effects.
(6)

o

o

o

o

o

I can make an
appointment
to screen for
late effects.
(7)

o

o

o

o

o

I know for
sure I can
make an
appointment
to screen for
late effects if
I really want
to. (8)

o

o

o

o

o

I know how
to go about
getting an
appointment
to screen for
late effects.
(9)

o

o

o

o

o

I can find a
place to have
an
appointment
to screen for
late effects.
(10)

o

o

o

o

o
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Q21 Cues to Action
Strongly
agree (1)

Agree (2)

Neutral (3)

Disagree (4)

Strongly
disagree (5)

I want to
discover
health
problems
early. (1)

o

o

o

o

o

Maintaining
good health is
extremely
important to
me. (2)

o

o

o

o

o

I search for
new
information
to improve
my health. (3)

o

o

o

o

o

I feel it is
important to
carry out
activities that
will improve
my health. (4)

o

o

o

o

o

I eat wellbalanced
meals. (5)

o

o

o

o

o

I exercise at
least three
times a week.
(6)

o

o

o

o

o

I have regular
health
checkups
even when I
am not sick.
(7)

o

o

o

o

o

Page Break
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Q22 Would you be willing to participate in a brief follow-up phone conversation about your
thoughts on late effects and screening for them?

o Yes (1)
o No (2)
Display This Question:
If Q22 = No
Q32 Please provide your e-mail if you wish to be entered into a drawing for a pair of wireless
Beats headphones.
Thank you for taking time out to participate in our survey. We truly value the information you
have provided us. Your responses are vital in helping to understand participation in late effects
screening and the development of future transition programs.
________________________________________________________________

Display This Question:
If Q22 = Yes
Q22a The next couple of questions are to collect contact information for the follow-up phone
call. Please provide your fist name:
________________________________________________________________

Display This Question:
If If The next couple of questions are to collect contact information for the follow-up phone
call. Please provide your fist name: Text Response Is Not Empty
Q22b Please provide the phone number you wished to be reached at:
________________________________________________________________
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Display This Question:
If If Please provide the phone number you wished to be reached at: Text Response Is Not
Empty
Q22c Please provide the e-mail address you wish to be reach at:
________________________________________________________________

Display This Question:
If If Please provide the phone number you wished to be reached at: Text Response Is Not
Empty
Please provide your e-mail if you wish to be entered into a drawing for a pair of wireless Beats
headphones.
Thank you for taking time out to participate in our survey. We truly value the information you
have provided us. Your responses are vital in helping to understand participation in late effects
screening and the development of future transition programs.
________________________________________________________________
End of Block: Default Question Block
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APPENDIX E PHONE INTERVIEW SCRIPT
Good Morning/ Afternoon, this is Kristen Trost, I am calling you as you opted to participate in a
follow-up phone interview as part of a study on young adult survivors of childhood cancer’s
participation in late effects screening. I’d like to confirm your willingness to still participate.
I am first going to ask you some demographic questions, followed by some questions about you
treatment, and followed by my last set of questions about your thoughts on late effects and
screening for them. This should take between 20 minutes and an hour, depending on how our
conversation goes. If at any time you feel uncomfortable or wish to stop please let me know.
Are you ready to proceed?
How old are you currently?
Would you please define your gender for me?
Female, Male, Transgender, Prefer not to answer
Would you please define you race/ethnicity for me?
What is the highest level of education you have completed?
What is your marital status?
What is your employment status?
My next set of questions is about your treatment history:
To the nearest year, how long has it been since you last received treatment for cancer?
To the nearest year, how old where you when you were diagnosed with cancer?
What was your diagnosis?
At any time following your original diagnosis, were you diagnosed with another cancer,
(leukemia, tumor, or similar illness)?
When did you last attend an appointment to screen for late effects?
My final set of questions is about your thought and feelings about late effects and attending
appointments to screen for late effects.
What comes to mind when you think about late effects?
How do you think late effects impact your life?
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Have you attended an appointment to screen for late effects in the past year?
What influences your decision on whether or not to make an appointment to screen for late
effects?
What things influence your decision to attend an appointment to screen for late effects?
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